Clinical Trials Search

Find upcoming clinical trial events for your portfolio.

NCT IDTitleStatusPrimary Completion DatePhasesCompaniesStart DateCompletion Date
NCT06716424A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes MellitusRECRUITING2026-04-03PHASE42025-01-062026-04-03
NCT06695130Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITING2026-04-03PHASE1, PHASE22024-11-182026-04-03
NCT05358249Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationACTIVE_NOT_RECRUITING2026-04-03PHASE1, PHASE22022-10-242026-05-18
NCT06622070A Study of SPY002-072 in Healthy VolunteersRECRUITING2026-04-03PHASE12024-11-182026-08-08
NCT05253651A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerRECRUITING2026-04-03PHASE32022-10-242029-07-27
NCT0567745124 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-upRECRUITING2026-04-02PHASE32023-07-112032-03-30
NCT06695117Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITING2026-04-01PHASE1, PHASE22024-11-192026-04-01
NCT02991469A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RECRUITING2026-04-01PHASE22018-08-092029-02-19
NCT06122662AMX0035 and Progressive Supranuclear PalsyACTIVE_NOT_RECRUITING2026-04-01PHASE2, PHASE32023-12-212029-11-30
NCT04278768Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)RECRUITING2026-04-01PHASE1, PHASE22020-07-062026-04-01
NCT06033586Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraACTIVE_NOT_RECRUITING2026-04-01PHASE32024-01-222027-04-01
NCT06961266A Study to Investigate Efficacy, Safety, Tolerability, and Pharmacokinetics of JZP441 Compared With Placebo in Participants With Narcolepsy Type 1RECRUITING2026-04-01PHASE12025-05-132026-04-01
NCT06625398An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)ACTIVE_NOT_RECRUITING2026-04-01PHASE32024-08-272026-12-15
NCT05429268Study to Evaluate the Safety and Efficacy of Tafasitamab Plus Lenalidomide in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (firmMIND)ACTIVE_NOT_RECRUITING2026-04-01PHASE32022-12-232027-04-01
NCT06162728Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Spontaneous Urticaria (CSU)RECRUITING2026-04-01PHASE1, PHASE22023-11-292026-04-01
NCT06144684A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295RECRUITING2026-04PHASE12023-11-292026-04
NCT05818150GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)RECRUITING2026-04NA2024-01-162027-10
NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32020-06-082026-04
NCT04785196APG-115 in Combination With PD-1 Inhibitor in Patients With Advanced Liposarcoma or Advanced Solid TumorsRECRUITING2026-04PHASE1, PHASE22021-05-262027-01
NCT04750226Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32021-02-182026-04
NCT06588491KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD-19 CAR T) Therapy, in Subject With Treatment Refractory Stiff Person SyndromeRECRUITING2026-04PHASE22024-09-252026-12
NCT06794866A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult ParticipantsACTIVE_NOT_RECRUITING2026-04PHASE32025-01-222026-04
NCT04965493A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)ACTIVE_NOT_RECRUITING2026-04PHASE32021-09-202027-01
NCT04198870MitraClip REPAIR MR StudyRECRUITING2026-04NA2020-07-212034-04
NCT06683508A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE22024-11-132026-09
NCT06977568A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the HipRECRUITING2026-04PHASE22025-07-252026-04
NCT07030127A Study of LY3985863 in Healthy ParticipantsRECRUITING2026-04PHASE12025-08-112026-04
NCT06161571A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)ACTIVE_NOT_RECRUITING2026-04PHASE32023-11-102026-10
NCT06615557Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder (PALISADE-4)RECRUITING2026-04PHASE32024-09-162026-10
NCT06337084Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid TumorsRECRUITING2026-04PHASE12024-05-302026-04
NCT05329584InSpace Accelerated Rehabilitation StudyRECRUITING2026-04NA2022-02-072026-12
NCT06235983A Study of LY3537982 in Chinese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-04PHASE12024-02-292027-04
NCT07011537Examining the Impact of a Digital Health Program and TENS Device for Patients With Chronic Low Back PainNOT_YET_RECRUITING2026-04NA2025-102026-10
NCT07090655A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy VolunteersRECRUITING2026-04EARLY_PHASE12025-08-112026-06
NCT06029972Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-04PHASE22023-12-052027-05
NCT06630299Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1ACTIVE_NOT_RECRUITING2026-04PHASE32024-10-082030-08
NCT05892614Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)RECRUITING2026-04PHASE22023-10-262026-04
NCT06979544A Study to Assess the Safety and Efficacy of Oral LPCN 1154A in Women With Severe PPDRECRUITING2026-04PHASE32025-06-162026-05
NCT04136171CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)ACTIVE_NOT_RECRUITING2026-04PHASE32020-03-132026-08
NCT06202339Alpha Radiation Emitters Device for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva (DaRT).NOT_YET_RECRUITING2026-04NA2024-042026-12
NCT07141199A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy VolunteersRECRUITING2026-04PHASE12025-09-022026-04
NCT06673238A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian ParticipantsRECRUITING2026-04PHASE12024-10-292026-04
NCT06312189Long-term Study to Evaluate Safety and Tolerability of Valbenazine in Participants With Chorea Associated With Huntington Disease in CanadaENROLLING_BY_INVITATION2026-04PHASE32024-04-242026-04
NCT06945419A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 DiabetesRECRUITING2026-04PHASE12025-04-232026-04
NCT05074420A Study of Baricitinib (LY3009104) in Children With COVID-19RECRUITING2026-04PHASE32021-12-212026-05
NCT06797375Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy ParticipantsRECRUITING2026-04PHASE12025-04-142026-06
NCT06630286Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1ACTIVE_NOT_RECRUITING2026-04PHASE32024-10-092030-08
NCT06897202A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DMRECRUITING2026-04PHASE22025-03-142026-06
NCT06650761A Phase I Study of CDX-622RECRUITING2026-04PHASE12024-11-012026-04
NCT06634420HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)ACTIVE_NOT_RECRUITING2026-04PHASE32025-01-152027-09
NCT06809179A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety DisorderRECRUITING2026-04PHASE22025-01-092026-12
NCT06588296Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE32024-09-242026-08
NCT06635057A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During RamadanRECRUITING2026-04PHASE42024-10-112026-04
NCT05302063A Study to Evaluate the Effect of Spinal Cord Stimulation (SCS) on Painful Diabetic Peripheral Neuropathy (pDPN)ACTIVE_NOT_RECRUITING2026-04NA2022-09-222026-04
NCT06556368A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAKRECRUITING2026-04PHASE32024-08-232027-04
NCT06834165Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients with Allergic Reactions After Oral Food Challenge or Allergen ImmunotherapyNOT_YET_RECRUITING2026-04PHASE42025-04-302026-06
NCT06982508Evaluation of Obicetrapib on Antioxidant Levels in Plasma and HDL Particles of Healthy VolunteersNOT_YET_RECRUITING2026-04PHASE22025-082026-06
NCT05929066A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE32023-07-102026-05
NCT06643728A Study to Investigate Weight Management With Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Adults With Obesity or OverweightACTIVE_NOT_RECRUITING2026-04PHASE22024-10-212027-01
NCT05980806A Study of Selinexor Monotherapy in Subjects with JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaRECRUITING2026-04PHASE22024-04-222028-10
NCT07006792A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch BurdenRECRUITING2026-04PHASE42025-06-162026-09
NCT06032416DenCT Shoulder Bone Quality EvaluationNOT_YET_RECRUITING2026-04NA2025-042027-04
NCT04088396A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)RECRUITING2026-04PHASE32020-02-122026-05
NCT06182969A Study of APG-2575 in Patients with Mild-to-moderate Systemic Lupus Erythematosus.RECRUITING2026-04PHASE1, PHASE22024-08-092026-12
NCT05882045A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular DiseaseACTIVE_NOT_RECRUITING2026-04PHASE32023-05-302026-05
NCT06774131A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerRECRUITING2026-03-31PHASE32025-05-022027-03-31
NCT05648591Safety and Tolerability of Open-Labeled Iloperidone in AdolescentsRECRUITING2026-03-31PHASE42023-05-242026-11-30
NCT03984097A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)ACTIVE_NOT_RECRUITING2026-03-31PHASE12019-07-292026-03-31
NCT04094311Study of Out of Specification for TisagenlecleucelRECRUITING2026-03-31PHASE32019-11-212026-03-31
NCT06909773The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular DiseasesNOT_YET_RECRUITING2026-03-31NA2025-09-302026-06-30
NCT05199701Prospective Case Collection Study for New Mammography TechnologiesRECRUITING2026-03-31NA2021-12-102026-03-31
NCT06831370A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRECRUITING2026-03-31PHASE42024-08-282026-03-31
NCT03786081Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical CancerACTIVE_NOT_RECRUITING2026-03-31PHASE1, PHASE22019-02-272026-03-31
NCT06643884Suprachoroidal Administration in Subjects With Metastases to the ChoroidRECRUITING2026-03-31PHASE22024-12-162027-02-28
NCT04420884A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-03-31PHASE1, PHASE22020-07-222026-03-31
NCT06357832New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)ACTIVE_NOT_RECRUITING2026-03-31NA2024-04-292026-04-30
NCT05303467A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMRECRUITING2026-03-31PHASE12022-07-302026-06-01
NCT04634552A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-03-31PHASE22021-02-012029-03-30
NCT02932618A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)RECRUITING2026-03-31PHASE32017-11-062026-03-31
NCT05048797A Study to Investigate the Efficacy and Safety of Trastuzumab Deruxtecan as the First Treatment Option for Unresectable, Locally Advanced/Metastatic Non-Small Cell Lung Cancer With HER2 MutationsRECRUITING2026-03-31PHASE32021-10-282027-07-30
NCT05939414An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.RECRUITING2026-03-31PHASE32024-03-122031-10-03
NCT06451614SpaceIT Hydrogel System for Perirectal SpacingRECRUITING2026-03-31NA2024-10-302028-03-31
NCT06267560Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVDACTIVE_NOT_RECRUITING2026-03-31PHASE32024-04-242026-03-31
NCT04553133PF-07104091 as a Single Agent and in Combination TherapyACTIVE_NOT_RECRUITING2026-03-30PHASE22020-09-162026-03-30
NCT05976243A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesRECRUITING2026-03-30PHASE32023-12-072028-12-31
NCT03175224APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsRECRUITING2026-03-30PHASE22017-09-272026-11-30
NCT05543681Clinical Trial on Agitation in Alzheimer's DementiaRECRUITING2026-03-30PHASE22022-10-112026-03-30
NCT04779918Ventral or Inguinal Hernia, Robotically Repaired With OviTex MeshRECRUITING2026-03-30NA2021-04-292027-12-30
NCT06115967A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of Subcutaneous AZD6912 in Healthy ParticipantsACTIVE_NOT_RECRUITING2026-03-30PHASE12023-11-152026-03-30
NCT06934226A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITING2026-03-30PHASE32025-04-152027-08-20
NCT06334991Study for Subjects with Relapsed/Refractory Non-Hodgkin LymphomaRECRUITING2026-03-30PHASE12024-08-232027-03-30
NCT03401788A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004)ACTIVE_NOT_RECRUITING2026-03-29PHASE22018-05-022026-03-29
NCT04895696A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)ACTIVE_NOT_RECRUITING2026-03-29PHASE22021-10-112029-04-22
NCT06430866Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)RECRUITING2026-03-27PHASE32024-09-122027-03-15
NCT06768671An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN)RECRUITING2026-03-27PHASE32024-12-302026-03-27
NCT04817618Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.RECRUITING2026-03-27PHASE32021-07-282026-07-04
NCT05180474GEN1047 for Solid Tumors - First in Human (FIH) TrialACTIVE_NOT_RECRUITING2026-03-26PHASE1, PHASE22021-12-132026-03-26
NCT06057038A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid TumorsACTIVE_NOT_RECRUITING2026-03-26PHASE12023-11-242026-12-26
NCT06719011A Study on How NNC0174-1213 Works in People With Overweight or Obesity.RECRUITING2026-03-26PHASE12024-12-032026-05-17
NCT05864846A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis ComplexACTIVE_NOT_RECRUITING2026-03-26PHASE42023-06-292026-03-26
NCT07146750A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult ParticipantsRECRUITING2026-03-25PHASE12025-08-252026-04-08
NCT06942936A Study to Investigate the Impact of Multiple Doses of Itraconazole on AZD5004 in Healthy Participants and Multiple Doses of AZD5004 on Combined Oral Ethinyl Oestradiol and Levonorgestrel in Healthy Female ParticipantsRECRUITING2026-03-25PHASE12025-05-282026-03-25
NCT06280391A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis BronchiectasisACTIVE_NOT_RECRUITING2026-03-24PHASE22024-02-202026-08-11
NCT05818553A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)RECRUITING2026-03-23PHASE2, PHASE32023-08-022027-03-01
NCT06952699A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)RECRUITING2026-03-23PHASE22025-05-062026-04-23
NCT06102005Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaACTIVE_NOT_RECRUITING2026-03-23PHASE22023-10-162026-03-23
NCT05174221A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background TherapyACTIVE_NOT_RECRUITING2026-03-23PHASE12022-11-092026-03-23
NCT05583526A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) TranquilloACTIVE_NOT_RECRUITING2026-03-22PHASE32022-12-012026-03-22
NCT03557619A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological MalignanciesRECRUITING2026-03-21PHASE12019-07-302026-03-21
NCT06887933A Trial to Evaluate the Safety of Niraparib Tablets in Adult Female Participants With Advanced or Relapsed Epithelial Ovarian CancerNOT_YET_RECRUITING2026-03-20PHASE42025-04-222026-07-08
NCT03460977Mevrometostat Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaRECRUITING2026-03-19PHASE12018-04-172026-03-19
NCT05776927A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.NOT_YET_RECRUITING2026-03-18PHASE32026-02-012029-02-01
NCT06529419A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of ExacerbationsRECRUITING2026-03-18PHASE22024-08-302026-04-06
NCT04585750The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)RECRUITING2026-03-17PHASE1, PHASE22020-10-292026-07-14
NCT06113471A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2)ACTIVE_NOT_RECRUITING2026-03-17PHASE32023-11-272027-03-16
NCT03997123Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBCACTIVE_NOT_RECRUITING2026-03-16PHASE32019-06-252026-03-16
NCT06830863A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityRECRUITING2026-03-15PHASE1, PHASE22025-08-252026-05-15
NCT05609812Atacicept in Subjects With Active Lupus Nephritis (COMPASS)WITHDRAWN2026-03-15PHASE32022-11-022028-12-15
NCT05618925Study for Subjects With Relapsed/Refractory Non- Hodgkin LymphomaRECRUITING2026-03-15PHASE12024-11-012027-03-15
NCT06710795AFFIX: Post-market Study of MaxTackâ„¢ Motorized Fixation Device in Subjects Undergoing Ventral Hernia RepairRECRUITING2026-03-15NA2024-11-262027-02-15
NCT05649722An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)ACTIVE_NOT_RECRUITING2026-03-14PHASE2, PHASE32023-05-112026-03-14
NCT07082426Early System Experience With the Abbott Balloon-expandable TAVI System: First-In-Human StudyACTIVE_NOT_RECRUITING2026-03-13NA2024-11-212026-05-30
NCT06308263Tuvusertib (M1774) Human Mass Balance and Absolute Bioavailability Study (DDRIVER Solid Tumors 303)RECRUITING2026-03-13PHASE12024-03-252026-03-13
NCT06012435A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-03-12PHASE32024-02-212028-03-11
NCT04225156A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).ACTIVE_NOT_RECRUITING2026-03-11PHASE32020-06-022026-03-11
NCT06134648Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidateACTIVE_NOT_RECRUITING2026-03-10PHASE1, PHASE22023-11-012026-03-10
NCT03333343Study of EGF816 in Combination With Selected Targeted Agents in EGFR-mutant NSCLCACTIVE_NOT_RECRUITING2026-03-09PHASE12018-01-292026-03-09
NCT07162610Efficacy and Safety of Rejuviel V in the Correction of Midface Volume DeficitACTIVE_NOT_RECRUITING2026-03-08NA2024-04-072026-03-30
NCT04895748DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other MalignanciesACTIVE_NOT_RECRUITING2026-03-06PHASE12021-11-302026-03-06
NCT04910776Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase AlfaACTIVE_NOT_RECRUITING2026-03-06PHASE32021-09-012027-08-10
NCT06295809A Study of (Neo)Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Cutaneous Squamous Cell Carcinoma (V940-007)ACTIVE_NOT_RECRUITING2026-03-05PHASE2, PHASE32024-04-182026-03-05
NCT06604767Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and OlderACTIVE_NOT_RECRUITING2026-03-05PHASE12024-09-172026-03-05
NCT06054113Study of Blinatumomab Administration in Chinese Pediatric Participants With Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)RECRUITING2026-03-04PHASE22024-07-232027-12-24
NCT05348577Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC)ACTIVE_NOT_RECRUITING2026-03-04PHASE32022-03-252026-03-04
NCT06132841A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or ObeseACTIVE_NOT_RECRUITING2026-03-04PHASE12023-11-132026-03-23
NCT06502366A Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With AsthmaRECRUITING2026-03-03PHASE32024-07-222026-03-03
NCT05250973A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisACTIVE_NOT_RECRUITING2026-03-03PHASE22022-03-012027-03-02
NCT04544189Study Assessing the Efficacy and Safety of Treatment With Alpelisib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Chinese Men and Postmenopausal Women With Advanced Breast CancerACTIVE_NOT_RECRUITING2026-03-02PHASE22021-01-202026-03-02
NCT06040086Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITING2026-03-02PHASE32023-09-222026-05-22
NCT03226808Vivacit-E Post-market Follow-up StudyACTIVE_NOT_RECRUITING2026-03-02NA2013-10-012028-06-30
NCT05648968A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaRECRUITING2026-03-02PHASE32022-12-302029-05-02
NCT06007690A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaRECRUITING2026-03-01PHASE32023-12-062027-03-01
NCT05866627A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy ParticipantsRECRUITING2026-03-01PHASE12023-07-042026-03-01
NCT05877963Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabRECRUITING2026-03-01PHASE32023-06-132026-03-01
NCT05061004Cephea Early Feasibility StudyRECRUITING2026-03-01NA2022-04-282031-03-01
NCT05743270Study of RP3 in Combination With Nivolumab and Other Therapy in Patients With Locoregionally Advanced or Recurrent SCCHNWITHDRAWN2026-03-01PHASE22024-01-302026-06-01
NCT06625411An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)ACTIVE_NOT_RECRUITING2026-03-01PHASE32024-08-272026-11-15
NCT05548127TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)ACTIVE_NOT_RECRUITING2026-03-01PHASE1, PHASE22023-02-232026-03-01
NCT05639751PRT3789 Monotherapy and in Combo w/Docetaxel in Participants w/Advanced or Metastatic Solid Tumors w/SMARCA4 MutationACTIVE_NOT_RECRUITING2026-03PHASE12023-05-022026-03
NCT06517316Cosmetic Contact Lenses Post-Market Clinical Follow-up StudyWITHDRAWN2026-03NA2025-012026-03
NCT06201416Study of Single Doses of SBT777101 in Subjects With Rheumatoid ArthritisRECRUITING2026-03PHASE12024-03-062026-03
NCT05544019Study of SGR-1505 in Mature B-Cell NeoplasmsRECRUITING2026-03PHASE12023-04-102026-03
NCT06947304Evaluation of Miricorilant on Liver Fat in Patients With MASLDRECRUITING2026-03PHASE12025-08-012026-03
NCT06891703[18F]ACI-15916 PET in α-synucleinopathiesRECRUITING2026-03EARLY_PHASE12025-03-202026-03
NCT04400331Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington DiseaseACTIVE_NOT_RECRUITING2026-03PHASE32020-09-182026-03
NCT06723171Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque PsoriasisNOT_YET_RECRUITING2026-03PHASE22025-062026-04
NCT06290934Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITING2026-03PHASE22024-03-272027-07
NCT05327959A.L.P.S. Clavicle Plating System PMCFENROLLING_BY_INVITATION2026-03NA2022-05-132027-03
NCT06079398A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Infants (0 to <2 Years of Age) With AchondroplasiaRECRUITING2026-03PHASE22024-01-232027-03
NCT07189013Assessing Patient Preference for Infusion SystemsNOT_YET_RECRUITING2026-03NA2025-10-152026-04
NCT06828861ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective TrialRECRUITING2026-03PHASE32024-12-202026-04
NCT05286229A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in JapanACTIVE_NOT_RECRUITING2026-03PHASE12022-03-242026-03
NCT06400303KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic SclerosisACTIVE_NOT_RECRUITING2026-03PHASE1, PHASE22024-08-062027-03
NCT05612581A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B InfectionACTIVE_NOT_RECRUITING2026-03PHASE1, PHASE22023-05-102027-03
NCT06343779Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaRECRUITING2026-03PHASE32024-02-262026-03
NCT07016750A Study Assessing KB803 Compared to Matching Placebo for the Treatment and Prevention of Corneal Abrasions in Dystrophic Epidermolysis BullosaRECRUITING2026-03PHASE32025-06-202026-03
NCT06031415Study of GS-0272 in Participants With Rheumatoid ArthritisRECRUITING2026-03PHASE12023-09-282026-03
NCT06747468Avexitide for Treatment of Post-Bariatric HypoglycemiaRECRUITING2026-03PHASE32025-04-292026-10
NCT05803421A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular RiskACTIVE_NOT_RECRUITING2026-03PHASE32023-04-032026-03
NCT07137689A Study of LY3537982 in Participants With Kidney Problems Compared With Participants With Normal Kidney FunctionNOT_YET_RECRUITING2026-03PHASE12025-082026-03
NCT06522035Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic ArthritisRECRUITING2026-03PHASE12024-08-012026-09
NCT02999009Trident II Tritanium Acetabular Shell Outcomes StudyACTIVE_NOT_RECRUITING2026-03NA2017-01-202031-03
NCT06692153Embecta AID System in Adults With Type 2 DiabetesWITHDRAWN2026-03NA2025-012026-05
NCT04401748Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic SyndromeACTIVE_NOT_RECRUITING2026-03PHASE32020-09-102026-03
NCT05924594Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301SUSPENDED2026-03PHASE32023-07-312026-03
NCT07065773Safety, Tolerability and Efficacy of Trichostatin A in Patients With Mild to Severe OnychomycosisRECRUITING2026-03PHASE22025-05-052026-05
NCT06539507A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725RECRUITING2026-03PHASE12024-09-262026-03
NCT06347159A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)RECRUITING2026-03PHASE22024-04-112026-03
NCT07069036A Study to Evaluate Single and Multiple Doses of SEP-631 in Healthy Adult VolunteersNOT_YET_RECRUITING2026-03PHASE12025-072026-04
NCT04868877Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationRECRUITING2026-03PHASE1, PHASE22021-04-282027-03
NCT06998043Study With Phage for CF Subjects With Pseudomonas Lung InfectionRECRUITING2026-03PHASE22025-07-022026-09
NCT06340451Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity SpasticityRECRUITING2026-03PHASE32024-04-162026-03
NCT05684796Comparison of Two Pulmonary Embolism TreatmentsACTIVE_NOT_RECRUITING2026-03NA2023-11-272026-10
NCT06602271PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NOT_YET_RECRUITING2026-03PHASE32025-032026-04
NCT05891171Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced CancersACTIVE_NOT_RECRUITING2026-03PHASE12023-10-132026-03
NCT05144243Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaACTIVE_NOT_RECRUITING2026-03PHASE42022-01-062026-03
NCT05768854Setrusumab vs Bisphosphonates in Pediatric Subjects With Osteogenesis ImperfectaACTIVE_NOT_RECRUITING2026-03PHASE32023-06-142027-04
NCT01679132BAROSTIM NEO Hypertension Pivotal TrialSUSPENDED2026-03NA2013-04-122026-03
NCT05226780Extension Study to Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEEACTIVE_NOT_RECRUITING2026-03PHASE22022-07-122026-03
NCT04562389Study of Selinexor in Combination With Ruxolitinib in MyelofibrosisACTIVE_NOT_RECRUITING2026-03PHASE32021-03-112028-03
NCT06223880A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsRECRUITING2026-03PHASE42023-12-272026-03
NCT06521554A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)RECRUITING2026-03PHASE12024-07-182026-03
NCT06411288Global Study of Del-desiran for the Treatment of DM1ACTIVE_NOT_RECRUITING2026-03PHASE32024-05-302026-09
NCT04951219A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)ACTIVE_NOT_RECRUITING2026-03PHASE32021-07-092026-04
NCT06049680Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult PatientsRECRUITING2026-03PHASE42024-10-282026-09
NCT05125809Setrusumab vs Placebo for Osteogenesis ImperfectaACTIVE_NOT_RECRUITING2026-03PHASE2, PHASE32022-02-212027-04
NCT05117476A Study of CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid TumorsRECRUITING2026-03PHASE12021-10-292026-06
NCT03893955A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-03PHASE12019-05-212026-03
NCT02988960A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-03PHASE12017-02-222026-03
NCT06858696A Study to Investigate Pharmacokinetics (PK) and Safety of a Single Dose of Mavorixafor in Participants With Hepatic Impairment (HI) Compared to Matched Healthy Volunteers With Normal Hepatic FunctionRECRUITING2026-03PHASE12025-02-282026-04
NCT06052852Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesACTIVE_NOT_RECRUITING2026-03PHASE12023-10-112028-03
NCT07024797Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese ParticipantsRECRUITING2026-03PHASE12025-08-212026-03
NCT04561362Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced MalignanciesRECRUITING2026-03PHASE1, PHASE22020-07-172026-12
NCT07165015A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal ImpairmentNOT_YET_RECRUITING2026-03PHASE12025-092026-03
NCT06374797A Study of Auxora in Patients With AKI and Injurious Lung "Crosstalk"RECRUITING2026-03PHASE22024-07-012026-03
NCT05016245MANDARIN (S6371)ACTIVE_NOT_RECRUITING2026-02-28PHASE32021-09-132026-10-30
NCT07063342A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Doses, and to Explore the Effect of Food After Multiple Doses of Selected Prototypes in Healthy Adult ParticipantsRECRUITING2026-02-28PHASE12025-06-272026-02-28
NCT05155605PATHFINDER 2: a Multi-Cancer Early Detection StudyACTIVE_NOT_RECRUITING2026-02-28NA2021-12-082028-04-30
NCT06799533A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid TumorsACTIVE_NOT_RECRUITING2026-02-28PHASE12025-05-012026-02-28
NCT05132075Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-02-28PHASE32022-06-152026-03-30
NCT06870487A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersACTIVE_NOT_RECRUITING2026-02-27PHASE12025-05-082026-02-27
NCT04619420A Study of JNJ-63733657 in Participants With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITING2026-02-27PHASE22021-01-062032-12-30
NCT04796337A Long-term Follow-up Study of Sotatercept for PAH Treatment (MK-7962-004/A011-12)ACTIVE_NOT_RECRUITING2026-02-27PHASE32021-05-122026-02-27
NCT06386419A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed DyslipidemiaACTIVE_NOT_RECRUITING2026-02-27PHASE42024-11-122026-02-27
NCT05660265A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 YearsRECRUITING2026-02-27PHASE12023-08-262026-02-27
NCT04023552Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVDACTIVE_NOT_RECRUITING2026-02-26PHASE32019-12-122026-02-26
NCT07071558Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of AgeACTIVE_NOT_RECRUITING2026-02-26PHASE12025-07-142026-02-26
NCT05811351A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)ACTIVE_NOT_RECRUITING2026-02-26PHASE22023-03-062026-02-26
NCT05588843Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisRECRUITING2026-02-25PHASE22022-11-252026-12-16
NCT05688475A Rollover Study of CC-122ACTIVE_NOT_RECRUITING2026-02-25PHASE12023-04-112026-02-25
NCT06113445A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V1)ACTIVE_NOT_RECRUITING2026-02-25PHASE32023-11-292027-02-24
NCT05592990A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles TendinopathyRECRUITING2026-02-24PHASE22023-06-142026-02-24
NCT05397223A Study of Modified mRNA Vaccines in Healthy AdultsACTIVE_NOT_RECRUITING2026-02-21PHASE12022-05-242026-02-21
NCT06221969A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorACTIVE_NOT_RECRUITING2026-02-20PHASE32024-01-162026-04-03
NCT04624659A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)ACTIVE_NOT_RECRUITING2026-02-20PHASE32021-01-292027-03-19
NCT05704049A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaRECRUITING2026-02-20PHASE22023-04-052028-05-18
NCT06181240Modification of Coronary Calcium With Laser Based Intravascular Lithotripsy for Coronary Artery Disease (FRACTURE)RECRUITING2026-02-20NA2023-11-172028-03-20
NCT06137729A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy AdultsRECRUITING2026-02-19PHASE12023-11-172026-02-19
NCT06196879A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)ACTIVE_NOT_RECRUITING2026-02-19PHASE22024-02-272026-06-11
NCT05852938A Study of Zigakibart in Adults With IgA NephropathyACTIVE_NOT_RECRUITING2026-02-19PHASE32023-07-062028-06-07
NCT07069725The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.RECRUITING2026-02-19PHASE12025-05-262026-02-19
NCT06812078A Study of TAK-360 in Adults With Idiopathic HypersomniaRECRUITING2026-02-19PHASE22025-02-072026-02-19
NCT06672718A Study of SPY002-091 in Healthy VolunteersRECRUITING2026-02-18PHASE12024-11-262026-06-22
NCT06143046A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated MothersACTIVE_NOT_RECRUITING2026-02-18PHASE22023-11-152026-02-18
NCT05831176A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May HaveACTIVE_NOT_RECRUITING2026-02-18PHASE22023-05-032026-11-25
NCT07190430A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female ParticipantsNOT_YET_RECRUITING2026-02-17PHASE12025-10-032026-02-17
NCT05703607A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy AdultsACTIVE_NOT_RECRUITING2026-02-17PHASE22023-01-252030-08-20
NCT06018558Study to Assess the Safety and Efficacy of OCU410 for Geographic AtrophyACTIVE_NOT_RECRUITING2026-02-17PHASE1, PHASE22023-02-232026-05-29
NCT04006808A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney TransplantRECRUITING2026-02-16PHASE1, PHASE22019-10-252027-03-31
NCT06531538A Study to Learn About How a New Pneumococcal Vaccine Works in ChildrenACTIVE_NOT_RECRUITING2026-02-16PHASE22024-07-302026-02-16
NCT04811560A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)RECRUITING2026-02-16PHASE1, PHASE22021-05-192028-05-26
NCT06454721A Study to Determine the Biodistribution, Safety, and Tolerability of a Microdose of Radiolabeled BIIB080 Co-administered With BIIB080 in Healthy AdultsRECRUITING2026-02-16PHASE12025-01-302026-07-30
NCT04898634A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerACTIVE_NOT_RECRUITING2026-02-13PHASE12021-07-132026-02-16
NCT07065331A Study of Inhaled AZD8630 in Adolescents With AsthmaRECRUITING2026-02-13PHASE12025-06-112026-02-13
NCT05572515A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple MyelomaRECRUITING2026-02-13PHASE32023-03-292031-08-31
NCT06299826A Phase IIb Study of AZD5462 in Patients With Chronic Heart FailureACTIVE_NOT_RECRUITING2026-02-12PHASE22024-06-042026-02-12
NCT05938270A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.RECRUITING2026-02-11PHASE12023-09-212026-02-11
NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)ACTIVE_NOT_RECRUITING2026-02-11PHASE32021-02-252027-02-11
NCT03767244A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical ProstatectomyACTIVE_NOT_RECRUITING2026-02-10PHASE32019-06-112029-07-19
NCT05755035A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesACTIVE_NOT_RECRUITING2026-02-10PHASE2, PHASE32023-10-242026-09-30
NCT06248619A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye DiseaseACTIVE_NOT_RECRUITING2026-02-10PHASE32024-07-052026-09-29
NCT05325866A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) OverexpressionACTIVE_NOT_RECRUITING2026-02-06PHASE1, PHASE22022-09-232026-02-06
NCT05455320A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentACTIVE_NOT_RECRUITING2026-02-06PHASE32022-10-132029-06-30
NCT05739942Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent GlioblastomaRECRUITING2026-02-05PHASE12024-05-152031-08-28
NCT05938387Safety and Tolerability of CVGBM in Adults with Newly Diagnosed MGMT-Unmethylated Glioblastoma or AstrocytomaACTIVE_NOT_RECRUITING2026-02-04PHASE12023-06-012026-02-04
NCT05552976A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)RECRUITING2026-02-04PHASE32023-01-102029-07-25
NCT04740476An Open-Label Extension Study of STK-001 for Patients With Dravet SyndromeENROLLING_BY_INVITATION2026-02-03PHASE22021-01-202027-03-03
NCT07019909A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese AdultsACTIVE_NOT_RECRUITING2026-02-03PHASE12025-07-062026-02-03
NCT06290128A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkRECRUITING2026-02-03PHASE32024-07-122027-10-12
NCT06096337Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial FibrillationACTIVE_NOT_RECRUITING2026-02-03NA2023-12-282028-02-03
NCT06974084Investigating Measurable PRO Acuity Trial (IMPACT) is a Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin to Improve Neurocognitive and Physical Function of Subjects With Long COVID-19/Post-Acute Sequelae of COVID-19 (PASC).NOT_YET_RECRUITING2026-02-01PHASE2, PHASE32025-09-012026-04
NCT02723994A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic LeukemiaACTIVE_NOT_RECRUITING2026-02-01PHASE22016-09-302026-02-01
NCT03564340Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersRECRUITING2026-02-01PHASE1, PHASE22018-05-212027-01-31
NCT06137157Evaluation of Topical ATR12-351 in Adults With Netherton SyndromeRECRUITING2026-02-01PHASE12024-06-192026-04-01
NCT04762069A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeACTIVE_NOT_RECRUITING2026-02-01PHASE22021-05-182026-03-31
NCT04838769REZŪM vs. Dual Drug Therapy for Symptomatic Benign Prostatic Hyperplasia in Sexually Active MenACTIVE_NOT_RECRUITING2026-02NA2021-09-152027-03
NCT06859294A Study of LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid ArthritisRECRUITING2026-02PHASE22025-03-192026-09
NCT06109181Gene Therapy for ACM Due to a PKP2 Pathogenic VariantRECRUITING2026-02PHASE1, PHASE22024-02-292027-02
NCT06953934A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male ParticipantsNOT_YET_RECRUITING2026-02PHASE12025-10-142026-02
NCT05540860A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)ACTIVE_NOT_RECRUITING2026-02PHASE22022-10-242026-02
NCT05848258An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid ArthritisRECRUITING2026-02PHASE22023-05-232026-07
NCT05711940Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRDRECRUITING2026-02PHASE32023-02-142026-12
NCT05703971Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC PatientsRECRUITING2026-02PHASE1, PHASE22024-05-092027-08
NCT06547125A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin QualityACTIVE_NOT_RECRUITING2026-02PHASE2, PHASE32024-07-182026-02
NCT05186974Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)ACTIVE_NOT_RECRUITING2026-02PHASE22022-05-302026-02
NCT03844048An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialACTIVE_NOT_RECRUITING2026-02PHASE32019-09-062026-02
NCT05149755Evolutâ„¢ EXPAND TAVR II Pivotal TrialACTIVE_NOT_RECRUITING2026-02NA2022-04-272034-12
NCT06637072A Study to Assess Adults With CIDP Transitioning From IVIg to Efgartigimod PH20 SCRECRUITING2026-02PHASE42024-12-102026-02
NCT05201404Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRECRUITING2026-02PHASE32023-03-152026-10
NCT06990399A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAKRECRUITING2026-02PHASE32025-07-302027-07
NCT02682511Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionACTIVE_NOT_RECRUITING2026-02PHASE22017-012026-05
NCT02399124Post Marketing Surveillance for PROSENSEâ„¢ a Cryotherapy Treatment of Renal Cell CarcinomaACTIVE_NOT_RECRUITING2026-02NA2014-072026-02
NCT06830746ASCEND CSP IDE StudyRECRUITING2026-02NA2025-04-112028-05
NCT04721015Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsACTIVE_NOT_RECRUITING2026-02PHASE12021-02-232026-02
NCT05804435iNodâ„¢ Ultrasound-Guided Needle Biopsy System StudyWITHDRAWN2026-02NA2025-012027-02
NCT05433142Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaRECRUITING2026-02PHASE12022-06-132027-11
NCT06525077Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)RECRUITING2026-02PHASE32024-08-012026-09
NCT05343481Efficacy of VTP-300 in Chronic Hepatitis B InfectionACTIVE_NOT_RECRUITING2026-02PHASE22022-09-212026-10
NCT05635643Study of CHS-114 in Participants With Advanced Solid TumorsRECRUITING2026-02PHASE12022-12-152026-02
NCT02625480Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaACTIVE_NOT_RECRUITING2026-02PHASE1, PHASE22016-02-012026-02
NCT06700538Study of ARO-INHBE in Adults With Obesity With and Without Diabetes MellitusRECRUITING2026-02PHASE1, PHASE22024-12-042026-02
NCT05566795DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)RECRUITING2026-02PHASE32023-02-272030-03
NCT06058039Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive DisorderRECRUITING2026-02PHASE32023-12-212026-03
NCT06869018A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese ParticipantsRECRUITING2026-02PHASE12025-05-072026-02
NCT05693142AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)RECRUITING2026-02PHASE2, PHASE32023-01-042028-08
NCT05249101A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic AdenocarcinomaRECRUITING2026-02PHASE1, PHASE22022-08-152026-06
NCT04262466Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint InhibitorsRECRUITING2026-02PHASE1, PHASE22020-02-252026-08
NCT04036682A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2026-01-31PHASE1, PHASE22019-10-312026-03-31
NCT06046443A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityACTIVE_NOT_RECRUITING2026-01-31PHASE22024-07-112026-01-31
NCT06241950A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Imlifidase Infusion in Participants With Duchenne Muscular Dystrophy (DMD) Determined to Have Pre-existing Antibodies to Recombinant Adeno-Associated Virus Serotype (rAAVrh74)ENROLLING_BY_INVITATION2026-01-31PHASE12024-01-292027-10-31
NCT04159103Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaRECRUITING2026-01-31PHASE1, PHASE22021-04-152026-01-31
NCT05686317ALT-FLOW II Trial of the Edwards APTURE Transcatheter Shunt SystemRECRUITING2026-01-31NA2023-04-012030-08-31
NCT05658237Clinical Study of PAL-222 Targeting Patients With Myopic Chorioretinal Atrophy (PAMyCA)ACTIVE_NOT_RECRUITING2026-01-31NA2023-02-172026-03-31
NCT06270836A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)ACTIVE_NOT_RECRUITING2026-01-31PHASE32024-05-012026-01-31
NCT03600883A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)ACTIVE_NOT_RECRUITING2026-01-31PHASE1, PHASE22018-08-272026-01-31
NCT05907954(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular MelanomaRECRUITING2026-01-31PHASE22023-07-032029-01-31
NCT05469737A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)ACTIVE_NOT_RECRUITING2026-01-31PHASE2, PHASE32022-12-142026-07-29
NCT06805513Actual Use Trial of Tadalafil 5 mgRECRUITING2026-01-31PHASE32025-01-302026-02-28
NCT06772597A Single-center Study of Setmelanotide in Patients With Prader-Willi SyndromeRECRUITING2026-01-31PHASE22025-03-042026-01-31
NCT06067828A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).RECRUITING2026-01-30PHASE32023-10-242026-01-30
NCT06500793Single and Multi-Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)RECRUITING2026-01-30PHASE12024-11-242026-03-27
NCT04471844Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBMACTIVE_NOT_RECRUITING2026-01-30NA2020-12-082026-01-30
NCT05660967Subcutaneous Epcoritamab With or Without Lenalidomide as First Line Therapy for Diffuse Large B-Cell LymphomaACTIVE_NOT_RECRUITING2026-01-30PHASE22023-03-062027-07-31
NCT03934372Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid TumorsRECRUITING2026-01-30PHASE1, PHASE22020-01-292026-01-30
NCT06941792Inclisiran Effectiveness in China: a Pragmatic Randomized TrialRECRUITING2026-01-30PHASE42025-06-172026-01-30
NCT05438043A Study of DaratumumabRECRUITING2026-01-30PHASE32022-12-152029-01-31
NCT05908734A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2026-01-30PHASE1, PHASE22023-05-182026-09-26
NCT05111626Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.ACTIVE_NOT_RECRUITING2026-01-29PHASE32022-03-142027-01-29
NCT07128615A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA)RECRUITING2026-01-29PHASE1, PHASE22025-09-042027-01-07
NCT05251259Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled AsthmaACTIVE_NOT_RECRUITING2026-01-29PHASE22022-01-272026-01-29
NCT06593600Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)RECRUITING2026-01-28PHASE22024-11-132026-04-21
NCT07135986Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaNOT_YET_RECRUITING2026-01-28PHASE32025-09-262026-06-29
NCT04480853Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple SclerosisRECRUITING2026-01-27PHASE42020-10-122026-01-27
NCT05583344Phase 2b Study of GSK4532990 in Adults With NASHACTIVE_NOT_RECRUITING2026-01-26PHASE22023-01-022027-04-05
NCT03924856Perioperative Pembrolizumab (MK-3475) Plus Neoadjuvant Chemotherapy Versus Perioperative Placebo Plus Neoadjuvant Chemotherapy for Cisplatin-eligible Muscle-invasive Bladder Cancer (MIBC) (MK-3475-866/KEYNOTE-866)ACTIVE_NOT_RECRUITING2026-01-26PHASE32019-06-132026-09-01
NCT06696170Evaluation of the CellFX® Nano-Pulsed Field Ablation (PFA) 360 Catheter Endocardial Ablation System for the Treatment of Atrial FibrillationRECRUITING2026-01-25NA2024-07-252026-04-25
NCT06699680Phase 1 Study of PRX019 in Healthy Adult VolunteersRECRUITING2026-01-23PHASE12024-11-082026-01-23
NCT06120504A Safety Study of PF-08046045/SGN-35T in Adults With Advanced CancersACTIVE_NOT_RECRUITING2026-01-21PHASE12024-02-292026-01-21
NCT05462873A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid TumorsACTIVE_NOT_RECRUITING2026-01-20PHASE12023-04-042026-01-20
NCT05166889Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of ExacerbationsACTIVE_NOT_RECRUITING2026-01-19PHASE32022-01-032026-03-23
NCT04530123Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free DietACTIVE_NOT_RECRUITING2026-01-19PHASE22022-06-232026-01-19
NCT06639997Safety and Tolerability of AZD5148 in Japanese ParticipantsACTIVE_NOT_RECRUITING2026-01-19PHASE12024-10-312026-01-19
NCT04193215V114 and Acute Otitis Media (V114-032/PNEU-ERA)ACTIVE_NOT_RECRUITING2026-01-19PHASE32020-09-122026-01-19
NCT05158387Efficacy and Safety of Tozorakimab in Symptomatic Chronic Obstructive Pulmonary Disease With a History of Exacerbations.ACTIVE_NOT_RECRUITING2026-01-19PHASE32022-02-072026-03-23
NCT05092347A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)RECRUITING2026-01-17PHASE1, PHASE22022-08-022026-12-12
NCT06104683A Study of Pirtobrutinib (LY3527727 [LOXO-305]) Versus Placebo in Participants With Relapsing Multiple SclerosisWITHDRAWN2026-01-16PHASE22024-05-012026-02-13
NCT03598608Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003)ACTIVE_NOT_RECRUITING2026-01-16PHASE1, PHASE22018-10-172026-01-16
NCT03723655A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCMACTIVE_NOT_RECRUITING2026-01-16PHASE2, PHASE32018-09-272026-01-16
NCT05322577A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.ACTIVE_NOT_RECRUITING2026-01-15PHASE1, PHASE22022-05-172028-03-12
NCT06590090Natrunix in Combination With Methotrexate for Rheumatoid Arthritis TreatmentNOT_YET_RECRUITING2026-01-15PHASE22025-07-152026-03-15
NCT05549323A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative ColitisACTIVE_NOT_RECRUITING2026-01-14PHASE12022-11-072026-01-14
NCT06103877A Placebo-controlled Safety and Tolerability Study of Intravenous (IV) and Subcutaneous (SC) AZD1163 in Healthy VolunteersACTIVE_NOT_RECRUITING2026-01-13PHASE12023-11-012026-01-13
NCT03485209Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid TumorsACTIVE_NOT_RECRUITING2026-01-13PHASE22018-06-252026-09-13
NCT07089784Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)RECRUITING2026-01-12PHASE12025-09-222026-01-12
NCT07068295A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin PumpRECRUITING2026-01-12PHASE12025-07-112026-01-12
NCT05925530Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)ACTIVE_NOT_RECRUITING2026-01-12PHASE22024-02-222027-08-27
NCT02684292Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)ACTIVE_NOT_RECRUITING2026-01-12PHASE32016-05-232026-01-12
NCT07160738A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060NOT_YET_RECRUITING2026-01-11PHASE12025-09-092026-01-11
NCT07121153A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants When Injected Under the Skin.RECRUITING2026-01-11PHASE12025-08-112026-01-11
NCT07086222Efficacy and Safety of NVX-CoV2705NOT_YET_RECRUITING2026-01-09PHASE42025-11-102026-07-09
NCT05144841A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)ACTIVE_NOT_RECRUITING2026-01-09PHASE22022-01-082026-01-09
NCT07002060Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsACTIVE_NOT_RECRUITING2026-01-08PHASE32025-05-222026-01-08
NCT06718998A Research Study Comparing Different Ways of Increasing the Dose of NNC0519-0130 in Participants With Overweight or ObesityRECRUITING2026-01-08PHASE12024-11-202026-01-08
NCT06845813Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD6234RECRUITING2026-01-08PHASE12025-02-242026-01-08
NCT05303532Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With DurvalumabENROLLING_BY_INVITATION2026-01-07PHASE32022-04-192026-12-31
NCT07013643A Study to Investigate the Effect of AZD6234 and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or ObesityRECRUITING2026-01-07PHASE12025-06-042026-01-07
NCT06968338A Study to Assess the Safety of ARGX-213 in Healthy VolunteersRECRUITING2026-01-06PHASE12025-04-112026-01-06
NCT07069309A Study to Learn About COVID-19 RNA-Based Variant-Adapted Vaccine Candidate(s) Against SARS-CoV-2 in Adults, Including Those at Higher Risk of Severe COVID-19RECRUITING2026-01-06PHASE32025-07-082026-01-06
NCT06403761Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 DiabetesACTIVE_NOT_RECRUITING2026-01-05PHASE12024-05-062026-02-13
NCT05002998TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement StudyACTIVE_NOT_RECRUITING2026-01-05PHASE42021-09-162026-01-05
NCT06390722A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic DermatitisWITHDRAWN2026-01-05PHASE32024-05-232026-07-08
NCT05975073A Phase 1/2 Study of AMG 193 in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid TumorsACTIVE_NOT_RECRUITING2026-01-05PHASE1, PHASE22023-08-012026-01-05
NCT07039929Study to Assess the Safety, Tolerability, and Pharmacokinetics of INCB000631 When Administered Orally to Healthy Adult ParticipantsRECRUITING2026-01-03PHASE12025-07-282026-01-03
NCT04957485Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOSACTIVE_NOT_RECRUITING2026-01-01PHASE22022-04-052026-01-01
NCT06870240A Randomised, Double-blind, Placebo-controlled Phase 2a Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ONP-002 in Adults With Mild Traumatic Brain InjuryNOT_YET_RECRUITING2026-01-01PHASE22025-06-012026-03-31
NCT04534127Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue NeoplasiaRECRUITING2026-01-01NA2020-12-222026-01-01
NCT06887959A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected SurgeriesRECRUITING2026-01-01PHASE42025-03-272026-01-15
NCT06045689A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome ParticipantsACTIVE_NOT_RECRUITING2026-01-01PHASE32023-10-052027-12-30
NCT06690996A Study of LY4005130 in Healthy ParticipantsRECRUITING2026-01PHASE12024-11-082026-01
NCT03652805A Study of IPL344 in the Treatment of ALS PatientsSUSPENDED2026-01PHASE1, PHASE22018-08-012026-02
NCT07169188A Clinical Study Investigating the Efficacy of an Experimental Toothpaste Containing Stannous Fluoride in Improving Gingival HealthRECRUITING2026-01NA2025-09-092026-01
NCT06209736Safety and Efficacy Study of OMS906 in Patients With C3G and ICGNRECRUITING2026-01PHASE22024-03-012026-04
NCT07119125A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRPRECRUITING2026-01PHASE12025-06-272026-03
NCT06782477A Study of STAR-0310 in Healthy Adult ParticipantsRECRUITING2026-01PHASE12025-012026-01
NCT06632002Diabetes-specific Formulas on Nutritional Outcomes in Individuals With Diabetes Who Require Nutritional SupportRECRUITING2026-01NA2025-01-022026-01
NCT06750809Randomized Controlled Trial to Investigate Clinical Outcomes and Associated Costs When PermeaDerm is Used as Temporary Dressing for Surgical WoundsRECRUITING2026-01NA2025-02-212026-02
NCT04731259Study to Evaluate the Safety of ATR-04WITHDRAWN2026-01PHASE1, PHASE22024-012026-01
NCT07120945Hugoâ„¢ Robotic-Assisted Surgery (RAS) System in Gynecological Subjects (Embrace Gynecology)RECRUITING2026-01NA2025-08-282031-05
NCT06668896Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal InsertNOT_YET_RECRUITING2026-01PHASE12025-112026-06
NCT05581199To Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPACTIVE_NOT_RECRUITING2026-01PHASE22022-12-152027-01
NCT06977880A Phase 1, First-in-human Study of MORF-440 (LY4292009) in Healthy ParticipantsRECRUITING2026-01PHASE12025-02-192026-01
NCT06714864Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of AgeRECRUITING2026-01PHASE42025-07-082026-03
NCT06354660Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)ACTIVE_NOT_RECRUITING2026-01PHASE32024-04-102026-02
NCT06309966Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset EpilepsyRECRUITING2026-01PHASE2, PHASE32024-05-132026-02
NCT06390592Clinical Performance of the Therapy Option FlexPoint of the PD Cycler Sleep•Safe HarmonyNOT_YET_RECRUITING2026-01NA2025-122026-12
NCT05191706Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood CataractRECRUITING2026-01PHASE42022-01-042026-02
NCT06026943Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters for the Treatment of Locally Advanced Pancreatic CancerNOT_YET_RECRUITING2026-01NA2025-012028-01
NCT06366750A Study of Barzolvolimab in Patients With Prurigo NodularisRECRUITING2026-01PHASE22024-04-122026-06
NCT07202871A Study of How the Body Absorbs LY3537031NOT_YET_RECRUITING2026-01PHASE12025-112026-09
NCT06916078A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver FunctionRECRUITING2026-01PHASE12025-04-232026-01
NCT03978689A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell CarcinomaACTIVE_NOT_RECRUITING2026-01PHASE12019-07-302026-01
NCT05571059Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)RECRUITING2026-01PHASE22024-01-312026-01
NCT04973618Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AMLWITHDRAWN2026-01PHASE12025-012027-01
NCT04799054A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2026-01PHASE1, PHASE22021-03-182026-03
NCT06223789VOLT-AF IDE Clinical StudyACTIVE_NOT_RECRUITING2026-01NA2024-04-032026-01
NCT06916143Comparing the Extent to Which Three Different Formulations of LY4100511 (DC-853) Are Made Available in the Body, Alone and in the Presence of a Drug That Reduces Stomach AcidRECRUITING2026-01PHASE12025-04-082026-01
NCT06239480SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic MalformationsRECRUITING2026-01PHASE32024-07-312026-07
NCT05887492Study of TNG260 and an Anti-PD Antibody in STK11 Mutated Solid TumorsRECRUITING2026-01PHASE1, PHASE22023-06-122026-06
NCT06605599Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II DisorderRECRUITING2026-01PHASE22024-10-152026-02
NCT06592521OPTI-FREE Family STUDYWITHDRAWN2026-01NA2025-102026-01
NCT06072612Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.RECRUITING2026-01PHASE32023-12-052026-06
NCT05411198Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle GlaucomaRECRUITING2026-01PHASE32022-07-222026-01
NCT05960240Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.ACTIVE_NOT_RECRUITING2026-01PHASE12023-08-302026-04
NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisACTIVE_NOT_RECRUITING2026-01PHASE32021-06-012026-01
NCT07070830Simplified Onboarding in Adults With Type 2 DiabetesRECRUITING2026-01NA2025-07-182026-01
NCT04760769Open-label Trial in Parkinson's Disease (PD)ACTIVE_NOT_RECRUITING2026-01PHASE32021-02-242026-01
NCT06588400AOSEPT (CLEAR CARE) PLUS StudyWITHDRAWN2026-01NA2025-102026-01
NCT06398730A Phase 1, Dose-Escalation, Positron Emission Tomography Study to Assess the Safety, Pharmacokinetics, Dosimetry and Biodistribution of GEH200521 (18F) Injection Co-Administered With GEH200520 Injection in Healthy VolunteersRECRUITING2026-01PHASE12024-07-022026-01
NCT06481280Evaluation of Tolerance, Efficacy and Safety of an Hydrolyzed Formula in Infants With IgE/Non-IgE Mediated CMA.ACTIVE_NOT_RECRUITING2026-01NA2024-08-142026-06
NCT06946524A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult ParticipantsACTIVE_NOT_RECRUITING2026-01PHASE12025-05-082026-01
NCT06584916A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)ACTIVE_NOT_RECRUITING2026-01PHASE32024-09-132026-01
NCT06127043A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)ACTIVE_NOT_RECRUITING2026-01PHASE22023-12-042026-05
NCT06014086Intratumoral PH-762 for Cutaneous CarcinomaRECRUITING2026-01PHASE12023-11-072026-04
NCT05783622Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor MalignanciesRECRUITING2026-01PHASE12023-04-192027-10
NCT06202118A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.RECRUITING2026-01NA2024-02-192026-06
NCT06777433Phase 2b Imaging Study of RAD101 in Participants With Suspected Recurrent Brain MetastasesRECRUITING2026-01PHASE22024-12-132026-06
NCT06787690Multicenter Single-arm Trial to Investigate Clinical Outcomes When Cohealyxâ„¢ is Used for Full Thickness WoundsRECRUITING2026-01NA2025-05-152026-06
NCT05139602A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic TherapyACTIVE_NOT_RECRUITING2026-01PHASE22021-12-282026-01
NCT06037252A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityACTIVE_NOT_RECRUITING2026-01PHASE22023-09-212026-10
NCT05705505Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic MalignanciesRECRUITING2026-01PHASE1, PHASE22023-03-292026-02
NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System AtrophyACTIVE_NOT_RECRUITING2026-01PHASE32023-06-272028-01
NCT04519749An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry DiseaseACTIVE_NOT_RECRUITING2026-01PHASE1, PHASE22020-09-012030-06
NCT07214740Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled SyringeNOT_YET_RECRUITING2026-01PHASE32025-102026-01
NCT04295538Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)ACTIVE_NOT_RECRUITING2026-01PHASE22020-09-062026-01
NCT04702880A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung CancerACTIVE_NOT_RECRUITING2025-12-31PHASE22021-03-172025-12-31
NCT03422822Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisACTIVE_NOT_RECRUITING2025-12-31PHASE32018-03-082025-12-31
NCT06435221Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersACTIVE_NOT_RECRUITING2025-12-31PHASE32024-05-282025-12-31
NCT02917993An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2025-12-31PHASE1, PHASE22016-12-202025-12-31
NCT05164055Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)ACTIVE_NOT_RECRUITING2025-12-31PHASE42022-07-112025-12-31
NCT05109728A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.RECRUITING2025-12-31PHASE12022-05-102026-02-25
NCT05926960A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab and Nivolumab) in Patients With Advanced MelanomaACTIVE_NOT_RECRUITING2025-12-31PHASE22023-06-132025-12-31
NCT05970263IKANOS: Breztri Maintenance Versus Any Non-Triple Inhaled Therapy After Hospitalization for a COPD Exacerbation in the USWITHDRAWN2025-12-31PHASE42024-01-192025-12-31
NCT03891953Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.ACTIVE_NOT_RECRUITING2025-12-31PHASE12019-05-072025-12-31
NCT05301842Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCCACTIVE_NOT_RECRUITING2025-12-31PHASE32022-03-282027-02-26
NCT06839209Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated DiarrheaRECRUITING2025-12-31NA2025-01-272025-12-31
NCT06396065Phase III Study of AK112 for NSCLC PatientsACTIVE_NOT_RECRUITING2025-12-31PHASE32023-05-042025-12-31
NCT05888844A Study to Evaluate INCB099280 in Participants With Advanced Cutaneous Squamous Cell CarcinomaACTIVE_NOT_RECRUITING2025-12-31PHASE22023-10-092026-12-31
NCT04620291Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation in HIV Infected AdultsNOT_YET_RECRUITING2025-12-31PHASE12023-12-312025-12-31
NCT04275518A Phase Ib Study of APG-115 Single Agent or in Combination With Azacitidine or Cytarabine in Patients With AML and MDS.RECRUITING2025-12-31PHASE12020-07-062025-12-31
NCT05464784MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and HypertriglyceridemiaRECRUITING2025-12-31PHASE22022-08-222026-12-31
NCT06790121A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisACTIVE_NOT_RECRUITING2025-12-31PHASE22025-02-032026-04-13
NCT03711032Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)ACTIVE_NOT_RECRUITING2025-12-31PHASE32018-12-242034-11-20
NCT04100148SyncAV Post-Market TrialACTIVE_NOT_RECRUITING2025-12-31NA2019-10-032025-12-31
NCT06685692A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1)RECRUITING2025-12-31PHASE22024-11-042025-12-31
NCT03491683INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)ACTIVE_NOT_RECRUITING2025-12-31PHASE1, PHASE22018-05-312025-12-31
NCT06432881Investigation of Skin Pigmentation Effect on Performance of Masimo Pulse Oximetry (INSPIRE)RECRUITING2025-12-31NA2024-01-082025-12-31
NCT05382364Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)ACTIVE_NOT_RECRUITING2025-12-31PHASE12022-06-292025-12-31
NCT03573310A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDSACTIVE_NOT_RECRUITING2025-12-31PHASE12018-07-132025-12-31
NCT05643534Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsRECRUITING2025-12-31PHASE32022-11-152025-12-31
NCT01872260Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast CancerACTIVE_NOT_RECRUITING2025-12-31PHASE1, PHASE22013-10-222025-12-31
NCT04756726Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaACTIVE_NOT_RECRUITING2025-12-31PHASE12021-04-272026-03-31
NCT05521438Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITING2025-12-31PHASE2, PHASE32022-06-232025-12-31
NCT05775159Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary CancerRECRUITING2025-12-31PHASE22023-04-242026-12-14
NCT07154901A Phase I Study to Investigate the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Opemalirsen (AZD2373)RECRUITING2025-12-31PHASE12025-08-182025-12-31
NCT03594422A Study of HQP1351 in Patients With GIST or Other Solid TumorsRECRUITING2025-12-31PHASE12018-07-112026-12-31
NCT04446351Study of the Safety and Effectiveness of GSK6097608 in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-12-31PHASE12020-06-252025-12-31
NCT07034768A Study to Evaluate EDG-7500 in People With Renal ImpairmentRECRUITING2025-12-31PHASE12025-07-222025-12-31
NCT03149211To Investigate the Efficacy and Safety of UB-421 Monotherapy in HIV-1 Infected AdultsWITHDRAWN2025-12-31PHASE32025-04-012025-12-31
NCT06850051A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.ACTIVE_NOT_RECRUITING2025-12-31PHASE12025-03-192025-12-31
NCT06219941AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2RECRUITING2025-12-30PHASE22023-12-132026-12-31
NCT05789056Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton SyndromeRECRUITING2025-12-30PHASE2, PHASE32023-03-142025-12-30
NCT04588922Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic MalignanciesRECRUITING2025-12-30PHASE1, PHASE22021-05-102025-12-31
NCT04354246COM902 (A TIGIT Inhibitor) in Subjects With Advanced MalignanciesACTIVE_NOT_RECRUITING2025-12-30PHASE12020-03-312025-12-30
NCT05866640Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRRECRUITING2025-12-30EARLY_PHASE12023-04-292026-01-30
NCT04279847Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid NeoplasmsRECRUITING2025-12-30PHASE12021-02-232026-12-30
NCT03611868A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-12-30PHASE1, PHASE22018-08-292025-12-30
NCT05877547A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)ACTIVE_NOT_RECRUITING2025-12-29PHASE22023-06-232025-12-29
NCT02651662A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell MalignanciesACTIVE_NOT_RECRUITING2025-12-27PHASE12016-01-112025-12-27
NCT07199452A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)NOT_YET_RECRUITING2025-12-27PHASE12025-10-282025-12-27
NCT05477524An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)ACTIVE_NOT_RECRUITING2025-12-26PHASE32022-08-042025-12-26
NCT05450562Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-12-25PHASE1, PHASE22022-09-202025-12-25
NCT03478462Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and OsteosarcomaACTIVE_NOT_RECRUITING2025-12-25PHASE12019-04-302026-12
NCT05375994Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC PatientsACTIVE_NOT_RECRUITING2025-12-24PHASE1, PHASE22022-08-012026-01-01
NCT02442752Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWITHDRAWN2025-12-23PHASE12025-06-152025-12-23
NCT04044859ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)ACTIVE_NOT_RECRUITING2025-12-23PHASE12019-08-202037-04-30
NCT06686797A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy AdultsRECRUITING2025-12-22PHASE12024-11-272025-12-22
NCT06821061A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy PeopleRECRUITING2025-12-22PHASE1, PHASE22025-02-102025-12-22
NCT07029412Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)RECRUITING2025-12-22PHASE22025-08-262026-01-26
NCT02952508Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom MacroglobulinemiaACTIVE_NOT_RECRUITING2025-12-22PHASE22017-07-262026-12-22
NCT05034497Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal MetastasesACTIVE_NOT_RECRUITING2025-12-21PHASE12021-12-062026-06-30
NCT04482062TRISCEND II Pivotal TrialACTIVE_NOT_RECRUITING2025-12-21NA2021-04-092030-06-27
NCT05668013A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseACTIVE_NOT_RECRUITING2025-12-20PHASE22023-01-112031-03-08
NCT06655870A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy ParticipantsRECRUITING2025-12-20PHASE12024-10-312025-12-20
NCT06704932A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the KneeACTIVE_NOT_RECRUITING2025-12-19PHASE12024-11-202025-12-19
NCT06579105Efficacy, Safety, and Tolerability of Once Daily Oral Administration of AZD5004 Versus Placebo for 26 Weeks in Adults With Type 2 Diabetes Mellitus.ACTIVE_NOT_RECRUITING2025-12-19PHASE22024-10-082025-12-19
NCT07198035A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144RECRUITING2025-12-19PHASE12025-09-182025-12-26
NCT06580587A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)RECRUITING2025-12-19PHASE12025-04-152025-12-19
NCT06887972A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive SurgeriesRECRUITING2025-12-18PHASE42025-03-212026-01-01
NCT05599191A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughACTIVE_NOT_RECRUITING2025-12-18PHASE32022-10-252026-05-28
NCT05617677A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)RECRUITING2025-12-17PHASE32023-01-122027-12-17
NCT05620407A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus ErythematosusRECRUITING2025-12-17PHASE32023-01-122027-12-17
NCT06551324A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).RECRUITING2025-12-17PHASE32024-10-212028-10-29
NCT06411639Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune DiseasesWITHDRAWN2025-12-17PHASE12024-11-252028-06-24
NCT06611033A Study of V118 Formulation C (V118C) in Healthy Participants (V118C-001)ACTIVE_NOT_RECRUITING2025-12-16PHASE12024-09-252025-12-16
NCT06810245Study of PIPE-791 for Subjects with Chronic Osteoarthritis Pain or Chronic Low Back PainRECRUITING2025-12-15PHASE12025-02-042026-02-15
NCT04657991A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaACTIVE_NOT_RECRUITING2025-12-14PHASE32021-01-152026-03-23
NCT06665828Phase 1 Safety and Tolerability Study of REGN9533 in Healthy AdultsRECRUITING2025-12-12PHASE12025-03-042025-12-12
NCT06442436A Study of Nemtabrutinib in Participants With Moderate Hepatic Impairment (MK-1026-015)RECRUITING2025-12-12PHASE12024-07-242025-12-12
NCT06727058Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and OlderACTIVE_NOT_RECRUITING2025-12-11PHASE1, PHASE22024-12-092026-10-13
NCT06995430A Phase 3 Study to Assess the Immune Response And Safety Of Rmenb+Omv Nz In Primed Healthy Participants (10 To 20 Years Old)RECRUITING2025-12-10PHASE32025-07-072025-12-10
NCT06694389Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 Vaccine (SARS-CoV-2 [COVID-19] and Influenza) in Adults ≥50 Years of AgeACTIVE_NOT_RECRUITING2025-12-10PHASE32024-11-182025-12-10
NCT06567041A Research Study of How Safe a New Medicine Called NNC0519 0130 is and to Test Its Effect in People Living With Excess Body Weight With or Without Type 2 DiabetesACTIVE_NOT_RECRUITING2025-12-10PHASE12024-08-072025-12-10
NCT03866109A Study Evaluating Temferon in Patients with Glioblastoma & Unmethylated MGMTRECRUITING2025-12-09PHASE1, PHASE22019-03-052025-12-09
NCT06579092Effects of AZD5004 in Adults Who Are Living With Obesity or Overweight With at Least 1 Weight-related ComorbidityACTIVE_NOT_RECRUITING2025-12-09PHASE22024-10-082025-12-09
NCT05020236A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsRECRUITING2025-12-09PHASE32021-10-042027-05-31
NCT07039981Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 DiabetesRECRUITING2025-12-08NA2025-07-012025-12-08
NCT05725902Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseACTIVE_NOT_RECRUITING2025-12-08PHASE22024-03-252026-02-26
NCT04607421A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal CancerACTIVE_NOT_RECRUITING2025-12-08PHASE32020-12-212027-12-28
NCT07025551A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)RECRUITING2025-12-08PHASE12025-09-192026-01-07
NCT03655678A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-ThalassemiaACTIVE_NOT_RECRUITING2025-12-08PHASE2, PHASE32018-09-142025-12-08
NCT05206773A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry DiseaseACTIVE_NOT_RECRUITING2025-12-07PHASE32022-03-112027-01-04
NCT05630183A Study of Botensilimab in Participants With Metastatic Pancreatic CancerACTIVE_NOT_RECRUITING2025-12-05PHASE22023-03-272025-12-05
NCT05996835Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (CLEAR-AKI)RECRUITING2025-12-04PHASE22024-01-182026-02-20
NCT05374512A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)ACTIVE_NOT_RECRUITING2025-12-03PHASE32022-05-162025-12-03
NCT05766501A Study of Doravirine/Islatravir (DOR/ISL, MK-8591A) for the Treatment of Human Immunodeficiency Virus 1 (HIV-1) Infection in Participants Who Previously Received DOR/ISL (MK-8591A-054)ACTIVE_NOT_RECRUITING2025-12-03PHASE32023-03-172028-09-06
NCT06238466A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With DyslipidemiaACTIVE_NOT_RECRUITING2025-12-02PHASE12024-01-162025-12-02
NCT05794230Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South AfricaACTIVE_NOT_RECRUITING2025-12-02PHASE32023-03-272025-12-02
NCT07016438Clinical Study of PAL-222 Targeting Patients With Refractory Skin UlcerRECRUITING2025-12-01NA2025-04-152025-12-31
NCT06989840Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without AcneRECRUITING2025-12-01PHASE12025-05-192026-01-01
NCT05348785A Study to Learn About the Safety of BIIB122 Tablets and Whether They Can Slow the Worsening of Early-Stage Parkinson's Disease in Adults Between the Ages of 30 and 80ACTIVE_NOT_RECRUITING2025-12-01PHASE22022-04-192025-12-15
NCT06757010A Study of NE3107 in Early Parkinson'sRECRUITING2025-12-01PHASE22025-03-262026-01-02
NCT06833190REGN5381 in Adult Participants With Uncontrolled HypertensionACTIVE_NOT_RECRUITING2025-12-01PHASE22025-04-162026-02-16
NCT05226507A Phase 1 Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian CancerACTIVE_NOT_RECRUITING2025-12PHASE12021-12-312025-12
NCT05262530Safety and Preliminary Efficacy Trial of BNT142 in Patients With CLDN6-positive Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22022-03-282025-12
NCT06615635Clinical Study Protocol for Cutaneous SCC for Immunocompromised PatientsNOT_YET_RECRUITING2025-12NA2025-122026-12
NCT06752668A Study of ORX750 in Participants With Narcolepsy and Idiopathic HypersomniaRECRUITING2025-12PHASE22024-12-232025-12
NCT05664243A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed GlioblastomaACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22023-09-082025-12
NCT04189614An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung CancerACTIVE_NOT_RECRUITING2025-12PHASE12020-02-132025-12
NCT06698926A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult ParticipantsRECRUITING2025-12PHASE12024-11-112025-12
NCT06488274Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant FormulaRECRUITING2025-12NA2024-10-212026-04
NCT03737734Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)ACTIVE_NOT_RECRUITING2025-12NA2018-12-312025-12
NCT06148272A Study of LY3971297 in Healthy ParticipantsRECRUITING2025-12PHASE12023-12-072025-12
NCT06999733A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic KeratitisRECRUITING2025-12PHASE1, PHASE22025-052026-10
NCT05459571Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell LymphomaACTIVE_NOT_RECRUITING2025-12PHASE22022-08-092025-12
NCT02446093Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic AdenocarcinomaACTIVE_NOT_RECRUITING2025-12PHASE22015-102026-07
NCT06836557Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisRECRUITING2025-12PHASE32024-01-092025-12
NCT05731947Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22023-04-042027-08
NCT02932150Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus InfectionACTIVE_NOT_RECRUITING2025-12PHASE22016-112029-10
NCT05266196A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)ENROLLING_BY_INVITATION2025-12PHASE1, PHASE22022-01-152025-12
NCT05413421Study of ORIC-944 in Patients With Metastatic Prostate CancerRECRUITING2025-12PHASE12022-06-012026-09
NCT06414603A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial BiopsyRECRUITING2025-12NA2024-06-102025-12
NCT06413433Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolRECRUITING2025-12PHASE32024-04-262025-12
NCT04442022A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaRECRUITING2025-12PHASE2, PHASE32020-09-032025-12
NCT06150742Nafamostat Efficacy in Phase 3 Registrational CRRT StudyRECRUITING2025-12NA2024-08-152025-12
NCT04639986Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)ACTIVE_NOT_RECRUITING2025-12PHASE32020-11-232025-12
NCT05307705A Study of LOXO-783 in Patients With Breast Cancer/Other Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE12022-05-112025-12
NCT02255383Persona Total Knee Arthroplasty Outcomes StudyACTIVE_NOT_RECRUITING2025-12NA2014-072027-12
NCT07157007Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19NOT_YET_RECRUITING2025-12PHASE22025-092026-01
NCT06682572A Study of Avutometinib + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer in Japanese PatientsRECRUITING2025-12PHASE22024-10-302027-10
NCT04607772Study of Selinexor in Combination With Backbone Treatments or Novel Therapies In Participants With Relapsed or Refractory (RR) Diffuse Large B-Cell Lymphoma (DLBCL)WITHDRAWN2025-12PHASE1, PHASE22020-11-182025-12
NCT06193200Evaluate the Neurological Effects of EryDex on Subjects With A-TACTIVE_NOT_RECRUITING2025-12PHASE32024-06-242025-12
NCT07046234Point of Care Lung Ultrasound Examination in Patients With Shortness of BreathENROLLING_BY_INVITATION2025-12NA2025-08-192025-12
NCT06824051A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or OverweightACTIVE_NOT_RECRUITING2025-12PHASE12025-02-172025-12
NCT04997902Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)ACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22021-12-072025-12
NCT04830137A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesRECRUITING2025-12PHASE12021-05-052026-12
NCT05931367A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the KneeACTIVE_NOT_RECRUITING2025-12PHASE32023-08-012025-12
NCT05375903A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)ACTIVE_NOT_RECRUITING2025-12PHASE12022-06-012025-12
NCT06709820A Study of LY4060874 in Healthy ParticipantsACTIVE_NOT_RECRUITING2025-12PHASE12024-12-022025-12
NCT06049082A Study of KB408 for the Treatment of Alpha-1 Antitrypsin DeficiencyRECRUITING2025-12PHASE12024-02-152026-12
NCT01906385Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)RECRUITING2025-12PHASE1, PHASE22015-06-032025-12
NCT06299839PAS-004 in Patients With Advanced Solid TumorsRECRUITING2025-12PHASE12024-02-292027-02
NCT05855083Efficacy and Safety Study of Narsoplimab in Pediatric Patients With High-Risk Hematopoietic Stem Cell Transplant TMARECRUITING2025-12PHASE22023-05-012025-12
NCT04374877Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE12020-04-222026-08
NCT05065346Neoadjuvant DaRT for Locally Advanced Oral Cavity SCCNOT_YET_RECRUITING2025-12NA2025-032026-06
NCT06848946Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneRECRUITING2025-12PHASE42025-01-132026-09
NCT06247085A Study to Investigate Efficacy and Safety of Pegtibatinase Compared With Placebo in Participants ≥12 to ≤65 Years of Age With Classical Homocystinuria (HCU) Due to Cystathionine Beta Synthase Deficiency Receiving Standard of Care TreatmentACTIVE_NOT_RECRUITING2025-12PHASE32023-12-282026-01
NCT06576843INDV-6001 Multiple-Dose Pharmacokinetic StudyACTIVE_NOT_RECRUITING2025-12PHASE22024-09-172025-12
NCT06964776A Study of LY4268989 (MORF-057) in Healthy ParticipantsRECRUITING2025-12PHASE12025-05-012025-12
NCT06973720A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or OverweightACTIVE_NOT_RECRUITING2025-12PHASE22025-04-012026-10
NCT05871970Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of AgeRECRUITING2025-12PHASE22023-10-182026-05
NCT05840224Study of GS-4528 in Adults With Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE12023-05-112025-12
NCT06719531SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 DiabetesWITHDRAWN2025-12NA2025-052025-12
NCT06333808Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyACTIVE_NOT_RECRUITING2025-12PHASE32024-03-252029-12
NCT05003843BOLT: Study of the Indigo® Aspiration System When Used in Patients With Deep Vein ThrombosisRECRUITING2025-12NA2021-09-302027-02
NCT06834789A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)ACTIVE_NOT_RECRUITING2025-12PHASE12025-02-182025-12
NCT04001777A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC PatientsACTIVE_NOT_RECRUITING2025-12PHASE12019-07-042026-06
NCT06653842A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous MalformationsRECRUITING2025-12PHASE22024-12-202026-03
NCT05172973ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesRECRUITING2025-12NA2023-11-222034-02
NCT05720039Robotic vs. Open NSM for Early Stage Breast CancerRECRUITING2025-12NA2023-05-082030-12
NCT05517421Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseACTIVE_NOT_RECRUITING2025-12PHASE32022-11-232025-12
NCT06703489Safety and Performance Assessment of the Sphere-9â„¢ Catheter and Afferaâ„¢ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)RECRUITING2025-12NA2025-03-182026-06
NCT06680232Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BRECRUITING2025-12PHASE12024-11-142026-12
NCT06099665Addressing Under-treatment and Health Equity in AS and MR Using an Integrated EHR PlatformRECRUITING2025-12NA2024-08-272025-12
NCT04229979Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2ACTIVE_NOT_RECRUITING2025-12PHASE32021-02-082026-12
NCT06333860A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)ACTIVE_NOT_RECRUITING2025-12PHASE42024-05-102026-03
NCT05614063A Randomized Study of XEN1101 Versus Placebo in Focal-Onset SeizuresACTIVE_NOT_RECRUITING2025-12PHASE32022-11-182026-02
NCT03767348Study of RP1 Monotherapy and RP1 in Combination With NivolumabRECRUITING2025-12PHASE22017-09-202028-12
NCT03995108Efficacy and Safety Study of Mavorixafor in Participants With Warts, Hypogammaglobulinemia, Infections, and Myelokathexis (WHIM) SyndromeACTIVE_NOT_RECRUITING2025-12PHASE32019-10-242025-12
NCT06385327A Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital HerpesRECRUITING2025-12PHASE12024-05-302025-12
NCT07056309A Study of Remternetug (LY3372993) in Healthy ParticipantsACTIVE_NOT_RECRUITING2025-12PHASE12025-06-242025-12
NCT05191667AN0025 and Chemoradiotherapy Combination in Esophageal CancerSUSPENDED2025-12PHASE12022-01-182025-12
NCT04628494A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)ACTIVE_NOT_RECRUITING2025-12PHASE32021-01-132028-04
NCT06492174A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion CohortACTIVE_NOT_RECRUITING2025-12PHASE32024-10-072027-12
NCT05559359A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic DermatitisRECRUITING2025-12PHASE32022-10-182026-12
NCT05047536KZR-261 in Subjects With Advanced Solid MalignanciesACTIVE_NOT_RECRUITING2025-12PHASE12021-09-302026-12
NCT06962774An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal FunctionRECRUITING2025-12PHASE12025-05-092025-12
NCT06558279A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia GravisRECRUITING2025-12PHASE32024-09-182027-12
NCT06769607Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical StudyNOT_YET_RECRUITING2025-12NA2025-032025-12
NCT04057898Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALSACTIVE_NOT_RECRUITING2025-12PHASE2, PHASE32020-05-282026-12
NCT03626038Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating SystemACTIVE_NOT_RECRUITING2025-12NA2018-06-192025-12
NCT06952634An Investigational Study of ESK-001 in Participants With Normal Liver Function and Participants With Mild, Moderate, and Severe Liver DamageRECRUITING2025-12PHASE12025-04-292025-12
NCT06962332Pharmacokinetics (PK) and Safety of Zanzalintinib in Participants With Moderate Hepatic Impairment (HI)RECRUITING2025-12PHASE12025-05-132026-04
NCT04083599GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22019-09-172026-11
NCT05968430Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With HypertensionACTIVE_NOT_RECRUITING2025-12PHASE32023-07-142026-12
NCT06538116A Study of Mevidalen (LY3154207) in Participants With Alzheimer's DiseaseRECRUITING2025-12PHASE22024-08-262026-01
NCT06158854A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) InfusionRECRUITING2025-12PHASE1, PHASE22024-04-012028-02
NCT04692181SYN-004 Safety and Tolerability in Allo-HCT SubjectsACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22021-02-152026-12
NCT05093634EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R PathwayACTIVE_NOT_RECRUITING2025-12PHASE32021-12-102025-12
NCT06555328Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis SuppurativaRECRUITING2025-12PHASE22025-01-022025-12
NCT04982835M6®-C Artificial Cervical Disc Two-Level IDE Pivotal StudyACTIVE_NOT_RECRUITING2025-12NA2021-07-262026-12
NCT03392324PRIMA US-Feasibility Study in Atrophic Dry AMDACTIVE_NOT_RECRUITING2025-12NA2018-04-262025-12
NCT06382675Clinical Performance of the New Plasma Filter PX2 in TPE TreatmentsRECRUITING2025-12NA2024-07-182026-03
NCT05323253A Clinical Study to Assess the Efficacy and Safety of Alpha DaRT224 for the Treatment of Patients With Recurrent Cutaneous Squamous Cell CarcinomaRECRUITING2025-12NA2022-09-212025-12
NCT06916065A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or ObesityRECRUITING2025-12PHASE12025-04-092025-12
NCT07024589First-in-Human Trial of Oral AN2-502998RECRUITING2025-12PHASE12025-08-042025-12
NCT05524571Study to Assess Batoclimab in Participants With Active Thyroid Eye DiseaseACTIVE_NOT_RECRUITING2025-12PHASE32023-01-052025-12
NCT07124013A Study of Olomorasib (LY3537982) in Healthy Japanese ParticipantsNOT_YET_RECRUITING2025-12PHASE12025-092025-12
NCT06945458Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)ACTIVE_NOT_RECRUITING2025-12PHASE12025-04-172025-12
NCT04498026Adherusâ„¢ Dural Sealant in Spinal ProceduresENROLLING_BY_INVITATION2025-12NA2020-11-192025-12
NCT03626688A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsACTIVE_NOT_RECRUITING2025-12PHASE32018-08-302025-12
NCT06333483A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)RECRUITING2025-12PHASE12024-02-022026-12
NCT05966493A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDRECRUITING2025-12PHASE22023-08-172025-12
NCT05829226A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)RECRUITING2025-12PHASE12022-12-122026-03
NCT05275478Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid TumorsACTIVE_NOT_RECRUITING2025-12PHASE1, PHASE22022-03-232025-12
NCT04652882Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)RECRUITING2025-12PHASE32020-12-092025-12
NCT06774313A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult ParticipantsRECRUITING2025-12PHASE12025-01-222025-12
NCT06423911Study of Olverembatinib (HQP1351) in Patients With CP-CMLRECRUITING2025-12PHASE32024-02-052026-02
NCT06393738A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.RECRUITING2025-12PHASE12024-09-052025-12
NCT06588283Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or OverweightACTIVE_NOT_RECRUITING2025-12PHASE32024-09-302026-05
NCT05126758A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular DystrophyACTIVE_NOT_RECRUITING2025-12PHASE32022-06-222027-12
NCT04781140Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHDRECRUITING2025-12PHASE42024-03-192025-12
NCT05504837A Study Assessing KB407 for the Treatment of Cystic FibrosisRECRUITING2025-12PHASE12023-06-302026-01
NCT03604198Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeACTIVE_NOT_RECRUITING2025-12PHASE22018-05-072025-12
NCT03838926Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesRECRUITING2025-12PHASE12018-09-272025-12
NCT05206513Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral PalsyACTIVE_NOT_RECRUITING2025-12PHASE32022-04-152026-06
NCT06373146A Study of Tirzepatide (LY3298176) Plus Mibavademab Compared With Tirzepatide Alone in Adult Participants With ObesityACTIVE_NOT_RECRUITING2025-12PHASE22024-04-242026-04
NCT04541082Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRECRUITING2025-12PHASE12020-10-262026-12
NCT05456256A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung AdenocarcinomaRECRUITING2025-12PHASE22023-03-012026-06
NCT07001319Study of GS-3242 in Participants With HIV-1RECRUITING2025-12PHASE12025-05-292027-02
NCT05473910A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem TransplantationRECRUITING2025-12PHASE12022-11-012026-06
NCT06163430CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid LeukemiaRECRUITING2025-11-30PHASE12024-03-262026-05-31
NCT06905873A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental VitiligoRECRUITING2025-11-30PHASE12025-03-252026-01-31
NCT06732180Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GT-02287 in Parkinson's DiseaseRECRUITING2025-11-30PHASE12025-02-212025-11-30
NCT04557098A Study of Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITING2025-11-30PHASE22020-09-172027-05-28
NCT06645834Smart MDI Study (CIP343)ACTIVE_NOT_RECRUITING2025-11-30NA2024-12-062025-11-30
NCT06549816A Study of SGN-B6A in Chinese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-11-28PHASE12024-08-212025-11-28
NCT06604026Investigational Study With the BD PosiFlushâ„¢ SafeScrub on NADsRECRUITING2025-11-28NA2024-10-222025-11-28
NCT04550260Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCCACTIVE_NOT_RECRUITING2025-11-28PHASE32020-10-192026-11-30
NCT06390059EF-39 PANOVA-4: Study of Tumor Treating Fields Concomitant With Atezolizumab, Gemcitabine and Nab-Paclitaxel as First-LineTreatment for Metastatic Pancreatic Ductal AdenocarcinomaACTIVE_NOT_RECRUITING2025-11-27PHASE22023-08-282025-11-27
NCT06181435A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)ACTIVE_NOT_RECRUITING2025-11-26PHASE32023-12-212026-03-17
NCT06436742A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)ACTIVE_NOT_RECRUITING2025-11-25PHASE12024-09-242025-11-25
NCT05565560A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITING2025-11-25PHASE32023-01-252026-09-06
NCT06908577An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of TozorakimabACTIVE_NOT_RECRUITING2025-11-25PHASE12025-04-072025-11-25
NCT06979518A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GSK3862995B Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and European AncestryNOT_YET_RECRUITING2025-11-25PHASE12025-05-202026-04-27
NCT07063238A Clinical Study of MK-8527 in Healthy Adult Participants (MK-8527-014)ACTIVE_NOT_RECRUITING2025-11-25PHASE12025-08-122025-12-15
NCT05110261Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in ChinaACTIVE_NOT_RECRUITING2025-11-24PHASE32021-11-242025-11-24
NCT06344104A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionACTIVE_NOT_RECRUITING2025-11-24PHASE32024-04-082026-04-03
NCT06894771A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001)ACTIVE_NOT_RECRUITING2025-11-24PHASE12025-04-232025-11-24
NCT06999902Double-blind, Randomized Trial of PRAX-628 in Adults With Focal Seizures to Evaluate Efficacy and Safety (POWER1)RECRUITING2025-11-24PHASE2, PHASE32024-12-112025-12-08
NCT06686628An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 SubstratesACTIVE_NOT_RECRUITING2025-11-23PHASE12024-11-202026-04-03
NCT07142642A Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Teprotumumab (AMG 632) Administered Intravenously in Healthy Chinese ParticipantsACTIVE_NOT_RECRUITING2025-11-22PHASE12025-08-262025-11-22
NCT03889912Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell CarcinomaACTIVE_NOT_RECRUITING2025-11-22PHASE12019-04-112026-02-02
NCT06860243A Study to Evaluate Opevesostat (MK-5684) in Male Participants With Moderate Hepatic Impairment (MK-5684-009)RECRUITING2025-11-22PHASE12025-05-132025-12-01
NCT06671834A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne VulgarisRECRUITING2025-11-21PHASE12024-11-222025-11-21
NCT07032272A Study to Investigate the Pharmacokinetics and Safety of Remibrutinib in Participants With Severe Renal Impairment Compared to Matched Healthy Participants.RECRUITING2025-11-21PHASE12025-07-232025-11-24
NCT06664801A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) (MK-7962-024)ACTIVE_NOT_RECRUITING2025-11-20PHASE22024-11-142025-11-20
NCT03485677Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3ACTIVE_NOT_RECRUITING2025-11-20PHASE32018-04-112025-11-20
NCT07121192A Study to Assess the Immune Response and Safety of a Vaccine Against Influenza in Adults 18 Years of Age and OlderNOT_YET_RECRUITING2025-11-20PHASE22025-09-012026-05-15
NCT06930664A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)ACTIVE_NOT_RECRUITING2025-11-19PHASE12025-05-162025-11-19
NCT03836040Efficacy and Safety of Erenumab in Pediatric Participants With Episodic MigraineACTIVE_NOT_RECRUITING2025-11-19PHASE32019-07-192026-10-13
NCT04404283Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCLACTIVE_NOT_RECRUITING2025-11-18PHASE32020-08-202025-11-18
NCT03081234Adjuvant Ribociclib With Endocrine Therapy in Hormone Receptor+/HER2- Intermediate Risk Early Breast CancerWITHDRAWN2025-11-17PHASE32018-03-312025-11-17
NCT03661320A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder CancerACTIVE_NOT_RECRUITING2025-11-17PHASE32018-11-062027-12-30
NCT06065540A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorACTIVE_NOT_RECRUITING2025-11-17PHASE32023-09-272026-01-05
NCT07049939A Study of Bomedemstat (MK-3543) in Participants With Mild or Moderate Hepatic Impairment (MK-3543-023)RECRUITING2025-11-16PHASE12025-08-202026-03-16
NCT06482359Lot Consistency Study of COVID-19 and Influenza Combination VaccineWITHDRAWN2025-11-16PHASE2, PHASE32025-02-012026-05-17
NCT03173703Evaluate Safety and Effectiveness of XenoSure® Biological Patch in the Application of Peripheral Vascular RepairACTIVE_NOT_RECRUITING2025-11-15NA2017-07-132025-11-15
NCT04677569Study to Evaluate ALIS (Amikacin Liposome Inhalation Suspension) in Participants With Nontuberculous Mycobacterial Lung Infection Caused by Mycobacterium Avium ComplexACTIVE_NOT_RECRUITING2025-11-15PHASE32021-04-012026-01-15
NCT06892249Suitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in TaiwanNOT_YET_RECRUITING2025-11-15NA2025-05-012026-04-30
NCT06148623Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin PigmentationSUSPENDED2025-11-14NA2023-11-132025-11-14
NCT04458051Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)ACTIVE_NOT_RECRUITING2025-11-14PHASE32020-08-132025-11-14
NCT05342636A Study of Combination Therapies With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer (MK-3475-06A)ACTIVE_NOT_RECRUITING2025-11-13PHASE1, PHASE22022-07-272025-11-13
NCT02719613Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating ElotuzumabACTIVE_NOT_RECRUITING2025-11-13PHASE22016-07-152025-11-13
NCT05630820Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)ACTIVE_NOT_RECRUITING2025-11-13PHASE32022-12-062026-05-08
NCT06409130Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseACTIVE_NOT_RECRUITING2025-11-13PHASE22024-05-202026-01-01
NCT05630807Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)ACTIVE_NOT_RECRUITING2025-11-12PHASE32022-12-072026-05-08
NCT05537025Study of ARO-MMP7 Inhalation Solution in Healthy Subjects and Patients With Idiopathic Pulmonary FibrosisACTIVE_NOT_RECRUITING2025-11-12PHASE1, PHASE22023-01-302025-11-12
NCT06929260A Study to Evaluate the Effect of Ceralasertib on Drug X, Drug Y and Drug ZRECRUITING2025-11-12PHASE12025-05-212026-03-02
NCT06101095A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)ACTIVE_NOT_RECRUITING2025-11-11PHASE42023-11-292028-02-01
NCT04788615Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMSACTIVE_NOT_RECRUITING2025-11-11PHASE32021-07-232026-02-13
NCT05606965A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1010 in Healthy AdultsRECRUITING2025-11-11PHASE22022-11-022025-11-11
NCT06502379A Single and Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of AZD8965 in Healthy Participants (Including Japanese and Chinese Participants) and an Open-label Cohort to Assess the Effect of Food on the Pharmacokinetics of AZD8965 in Healthy ParticipantsRECRUITING2025-11-10PHASE12024-08-022025-11-10
NCT06283498Transvaginal Detrusor Nerve Radiofrequency Ablation for Treatment of Overactive BladderENROLLING_BY_INVITATION2025-11-10NA2023-11-102027-11-10
NCT06814119A Clinical Study of MK-1084 in Participants With Renal Impairment (MK-1084-010)RECRUITING2025-11-10PHASE12025-04-072025-11-21
NCT06563102Study to Investigate Changes in Airway Inflammation, Symptoms, and Rescue Therapy Utilization With AIRSUPRA Compared to Albuterol as Needed in Adults With Mild AsthmaRECRUITING2025-11-10PHASE42024-09-112025-11-10
NCT06469151A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy AdultsACTIVE_NOT_RECRUITING2025-11-07PHASE12024-06-242025-11-07
NCT06290141A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RECRUITING2025-11-05PHASE32024-08-212027-11-19
NCT07127770A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy ParticipantsNOT_YET_RECRUITING2025-11-05PHASE12025-08-282025-11-05
NCT05878184Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)ACTIVE_NOT_RECRUITING2025-11-04PHASE12023-05-022038-11-04
NCT06125522TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)ACTIVE_NOT_RECRUITING2025-11-04PHASE1, PHASE22024-01-102025-11-04
NCT03328026Combination Study of SV-BR-1-GM With RetifanlimabENROLLING_BY_INVITATION2025-11-03PHASE1, PHASE22018-03-162028-11-30
NCT07102316A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy ParticipantsRECRUITING2025-11-02PHASE12025-08-192025-11-09
NCT07101783A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or ObesityRECRUITING2025-11-02PHASE12025-08-012025-11-02
NCT06038474Descartes-08 for Patients With Systemic Lupus ErythematosusRECRUITING2025-11-01PHASE22024-02-122026-11-01
NCT06053242Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back PainRECRUITING2025-11-01PHASE1, PHASE22024-05-212026-10-01
NCT06928129Clinical Feasibility of the BinaxNOWâ„¢ COVID-19/Flu A&B Combo in the Southern HemisphereNOT_YET_RECRUITING2025-11-01NA2025-06-302025-11-01
NCT06841315A Varegacestat Hepatic Impairment StudyRECRUITING2025-11PHASE12025-03-072025-12
NCT06088979A Study to Investigate Efficacy and Safety of TOUR006 in Participants 18 to 80 Years of Age With Thyroid Eye DiseaseRECRUITING2025-11PHASE22024-02-192026-11
NCT03526835A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid TumorsRECRUITING2025-11PHASE1, PHASE22018-05-022027-11
NCT03432286A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic MigraineRECRUITING2025-11PHASE32018-03-142026-11
NCT05490446A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)RECRUITING2025-11PHASE22022-11-072028-11
NCT06698575A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesRECRUITING2025-11PHASE12024-12-082025-12
NCT06662279Hyrax Vs. Invisalign Palatal Expander Clinical StudyRECRUITING2025-11NA2024-10-252026-01
NCT06555783A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2ACTIVE_NOT_RECRUITING2025-11PHASE22024-07-262025-11
NCT06849791A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE12025-02-262025-12
NCT05936151A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesACTIVE_NOT_RECRUITING2025-11PHASE22023-07-202025-11
NCT05934526Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)ACTIVE_NOT_RECRUITING2025-11PHASE32023-12-282025-12
NCT06441643Next Generation RocklatanACTIVE_NOT_RECRUITING2025-11PHASE22024-09-042025-11
NCT06203054CLIP-IT Post-Market StudyACTIVE_NOT_RECRUITING2025-11NA2024-02-262029-02
NCT05818709A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE32023-06-142025-11
NCT03922048Pediatric Postoperative Analgesia Herniorrhaphy StudyWITHDRAWN2025-11PHASE22023-072025-12
NCT06780332Rapid Drug Desensitization Study in Adults Experiencing Hypersensitivity Reactions to PalynziqRECRUITING2025-11PHASE42025-012025-11
NCT07007091A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE12025-06-122025-12
NCT06546995Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's DiseaseRECRUITING2025-11PHASE12024-07-092025-11
NCT06340360A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Severe to Very Severe Alopecia Areata in Adult Patients (Rezolve AA)ACTIVE_NOT_RECRUITING2025-11PHASE22024-04-022026-08
NCT03732898Coordinated Reset Deep Brain StimulationRECRUITING2025-11NA2019-01-132025-11
NCT04641143Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive DisorderACTIVE_NOT_RECRUITING2025-11PHASE32020-12-222025-11
NCT06419608Efficacy and Safety Study of BHV-7000 Monotherapy in Major DepressionACTIVE_NOT_RECRUITING2025-11PHASE22024-05-282025-12
NCT06847191NE3107 in Adults With Neurological Symptoms of Long COVIDRECRUITING2025-11PHASE22025-04-292026-01
NCT04009681A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)ACTIVE_NOT_RECRUITING2025-11PHASE1, PHASE22019-06-202025-11
NCT05322070Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment UveitisACTIVE_NOT_RECRUITING2025-11PHASE42022-06-062025-11
NCT06698549A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects with Renal Impairment and in Healthy Subjects with Normal Renal FunctionRECRUITING2025-11PHASE12025-02-012026-02
NCT05491317A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid TumorsACTIVE_NOT_RECRUITING2025-11PHASE1, PHASE22023-03-082025-11
NCT05291234A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITING2025-11PHASE22022-08-152025-11
NCT06557356A Study of LY3532226 in Participants With ObesityACTIVE_NOT_RECRUITING2025-11PHASE12024-08-162025-11
NCT05657743A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic CancerRECRUITING2025-11NA2023-08-162025-11
NCT06921590A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult SubjectsACTIVE_NOT_RECRUITING2025-11PHASE12025-05-092025-12
NCT07071532A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE12025-07-152025-11
NCT07051252A Study of HBS-201 (Pitolisant Delayed-release)RECRUITING2025-11PHASE12025-05-212025-11
NCT06068855A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE32023-10-172025-11
NCT06911320Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic FunctionRECRUITING2025-11PHASE12025-04-092025-11
NCT05907096ARGX-117 in Deceased Donor Kidney Transplant Recipients at Risk for Delayed Graft FunctionACTIVE_NOT_RECRUITING2025-11PHASE22024-02-172026-07-31
NCT06190899Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate CancerRECRUITING2025-11PHASE1, PHASE22024-01-012027-11
NCT06387394A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle ProminenceACTIVE_NOT_RECRUITING2025-11PHASE32024-04-222025-11
NCT05359445IMA401 TCER® in Recurrent and/or Refractory Solid Tumors, Alone or in Combination With a Checkpoint InhibitorRECRUITING2025-11PHASE12022-05-192029-12
NCT05741476Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Children 4-7 Years of AgeACTIVE_NOT_RECRUITING2025-11PHASE32023-02-212029-10
NCT06297616A Study of LY3841136 in Japanese Participants With Obesity or OverweightACTIVE_NOT_RECRUITING2025-11PHASE12024-04-152025-11
NCT06292923A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis PatientsRECRUITING2025-11PHASE22023-11-152025-11
NCT07110441Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy VolunteersRECRUITING2025-11PHASE12025-08-262025-12
NCT06492746Personal BP - CAI StudyRECRUITING2025-11NA2024-06-032025-12
NCT05799274Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic CancerRECRUITING2025-11PHASE12023-11-092025-11
NCT06937619A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE12025-04-212025-11
NCT06185543A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.RECRUITING2025-11PHASE22023-11-192025-11
NCT04670679A Dose Escalation/Expansion Study of ERAS-601 in Patients With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITING2025-11PHASE12020-12-152026-02
NCT06399718A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsACTIVE_NOT_RECRUITING2025-11PHASE32024-04-302025-11
NCT06400511A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic OintmentACTIVE_NOT_RECRUITING2025-11PHASE32024-04-222025-12
NCT06980649Study of BHV-1300 in Graves' DiseaseRECRUITING2025-11PHASE12025-08-212026-03
NCT05105841Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITING2025-11PHASE22021-11-082025-11
NCT06496243Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) LevelsRECRUITING2025-11PHASE22024-12-022026-02
NCT06384157Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use DisorderACTIVE_NOT_RECRUITING2025-11PHASE22024-06-102025-12
NCT06742853A Study to Investigate the Pharmacokinetics, Safety, Tolerability, and Efficacy of AZD0780 With Ezetimibe Combinations in Healthy Adults With Elevated LDL-C.ACTIVE_NOT_RECRUITING2025-10-31PHASE12024-12-202025-10-31
NCT03037164INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted InfectionsRECRUITING2025-10-31PHASE32017-05-112026-01-30
NCT05666804Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal VasculopathyACTIVE_NOT_RECRUITING2025-10-31PHASE32023-02-062025-10-31
NCT02625961Study of Pembrolizumab (MK-3475) and Pembrolizumab With Other Investigational Agents in Participants With High Risk Non-muscle Invasive Bladder Cancer (MK-3475-057/KEYNOTE-057)ACTIVE_NOT_RECRUITING2025-10-31PHASE22016-02-102025-10-31
NCT04165083KEYMAKER-U01 Substudy 2: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Treatment-naïve Participants With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Positive Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01B/KEYMAKER-U01B)ACTIVE_NOT_RECRUITING2025-10-31PHASE22020-12-222025-10-31
NCT04809363A Study of CDPATHâ„¢ to Help Manage and Treat Crohn's DiseaseACTIVE_NOT_RECRUITING2025-10-31PHASE42021-06-252026-06-30
NCT05513586A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) ParticipantsACTIVE_NOT_RECRUITING2025-10-31PHASE32022-09-132025-10-31
NCT06742957Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque PsoriasisACTIVE_NOT_RECRUITING2025-10-31PHASE32024-12-172025-11-28
NCT05413018An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Acute Myeloid Leukemia in Complete RemissionACTIVE_NOT_RECRUITING2025-10-31PHASE22022-08-192026-03-01
NCT04390399Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerACTIVE_NOT_RECRUITING2025-10-31PHASE22020-07-212025-10-31
NCT06465485STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic AsthmaACTIVE_NOT_RECRUITING2025-10-31PHASE32024-02-282026-03-31
NCT04639466A Synthetic MVA-based SARS-CoV-2 Vaccine, GEO-CM04S1, for the Prevention of COVID-19 InfectionACTIVE_NOT_RECRUITING2025-10-31PHASE1, PHASE22020-11-192026-02-28
NCT04215809Study of APG-2575 as a Single Agent or in Combination With Other Therapeutic Agents for CLL/SLLRECRUITING2025-10-31PHASE12020-03-022027-06-30
NCT06248814A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic DermatitisACTIVE_NOT_RECRUITING2025-10-31PHASE12024-03-062025-10-31
NCT05647161BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial)ACTIVE_NOT_RECRUITING2025-10-31NA2022-12-082025-12-31
NCT05118789A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)RECRUITING2025-10-31PHASE1, PHASE22022-01-042026-10-31
NCT06271837A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing TumorsRECRUITING2025-10-30PHASE22024-02-182027-04-01
NCT06582056Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of AgeRECRUITING2025-10-30NA2024-10-092025-10-30
NCT05720455Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and AboveNOT_YET_RECRUITING2025-10-30PHASE42025-06-062025-10-30
NCT06020014Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABAACTIVE_NOT_RECRUITING2025-10-30PHASE22023-11-162025-10-30
NCT06717425A Study to Learn About the Study Medicine Called PF-07976016 in Adults With ObesityACTIVE_NOT_RECRUITING2025-10-30PHASE22024-12-092025-12-04
NCT04417621Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic MelanomaACTIVE_NOT_RECRUITING2025-10-29PHASE22020-10-302025-10-30
NCT06585241A Study to Investigate the Immunogenicity of mRNA COVID-19 Variant-containing Vaccine Formulations in Adults to Prevent COVID-19ACTIVE_NOT_RECRUITING2025-10-29PHASE42024-09-092025-10-29
NCT06877702A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male ParticipantsRECRUITING2025-10-29PHASE12025-03-192025-10-29
NCT07018635A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy ParticipantsRECRUITING2025-10-29PHASE12025-07-162025-10-29
NCT05436834A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of AgeRECRUITING2025-10-27PHASE32022-06-212025-10-27
NCT06675175A Phase 1b Study to Assess the Safety, Tolerability, and Pharmacodynamics of AZD4144 in Participants With Established Atherosclerotic Cardiovascular and Chronic Kidney Disease.RECRUITING2025-10-27PHASE12024-12-092025-10-27
NCT05156710BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)ACTIVE_NOT_RECRUITING2025-10-27PHASE22022-06-092026-11-17
NCT07130097A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy ParticipantsNOT_YET_RECRUITING2025-10-25PHASE12025-08-142025-11-18
NCT05624580A Study to Look at Safety and Tolerability of NNC0582-0001, How it is Transported Throughout the Body and How it Works in Healthy AdultsACTIVE_NOT_RECRUITING2025-10-25PHASE12022-11-152025-10-25
NCT07022977A Study of MET233 in Individuals With Obesity or OverweightRECRUITING2025-10-24PHASE1, PHASE22024-11-202026-01-03
NCT07174596Evaluation of Approved Contact LensesNOT_YET_RECRUITING2025-10-24NA2025-09-122025-10-24
NCT06681181A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy ParticipantsRECRUITING2025-10-23PHASE12024-11-182026-09-09
NCT05834738Randomized, Double-blind, Placebo-controlled, Crossover Study of Atrasentan in Subjects With IgA NephropathyACTIVE_NOT_RECRUITING2025-10-22PHASE22023-07-202026-08-19
NCT06846866A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy ParticipantsRECRUITING2025-10-22PHASE12025-02-272025-10-22
NCT05134948A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-10-22PHASE1, PHASE22021-11-302025-10-22
NCT04514653RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)RECRUITING2025-10-21PHASE22020-08-252026-08-01
NCT06532032A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With Metastatic Non-small Cell Lung CancerACTIVE_NOT_RECRUITING2025-10-21PHASE1, PHASE22024-07-232026-06-09
NCT04175613A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque PsoriasisACTIVE_NOT_RECRUITING2025-10-21PHASE32019-12-202025-12-16
NCT06546553A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.ACTIVE_NOT_RECRUITING2025-10-21PHASE12024-09-062025-10-21
NCT05586321Study of Safety and Antitumor Activity of GEN1056 in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITING2025-10-21PHASE12022-10-242025-10-21
NCT06079476A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.ACTIVE_NOT_RECRUITING2025-10-21PHASE42023-10-302025-10-21
NCT06935266A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy AdultsRECRUITING2025-10-21PHASE12025-04-222025-10-21
NCT05957406SMART TRENDS StudyRECRUITING2025-10-20NA2023-07-112026-06
NCT06104566Global Trial in APG2575 for Patients With CLL/SLLRECRUITING2025-10-20PHASE32023-12-202027-10-31
NCT05705349DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)ACTIVE_NOT_RECRUITING2025-10-19PHASE32023-03-082029-08-05
NCT05648214A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Non-Alcoholic Fatty Liver Disease (NAFLD)ACTIVE_NOT_RECRUITING2025-10-18PHASE12022-12-272025-10-18
NCT03319940Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)ACTIVE_NOT_RECRUITING2025-10-18PHASE12017-12-262026-10-18
NCT07075640A Study to Determine the Safety and Tolerability of AG-236 and How it is Absorbed, Broken Down, and Eliminated From the Body in Healthy ParticipantsRECRUITING2025-10-17PHASE12025-07-072025-12-12
NCT06723535A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent HemodialysisRECRUITING2025-10-17PHASE12024-12-072025-10-17
NCT07149415A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55RECRUITING2025-10-16PHASE12025-09-022025-10-16
NCT06663436A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in InfantsACTIVE_NOT_RECRUITING2025-10-16PHASE22024-11-132025-10-16
NCT06994936An Open-label Study in Healthy Adults to Evaluate the Relative Bioequivalence of a Single-dose Administration of Sonelokimab Either by a Prefilled Syringe or an AutoinjectorACTIVE_NOT_RECRUITING2025-10-16PHASE12025-06-052025-10-16
NCT05032040A Study of XmAb20717 (Vudalimab)in Patients With Selected Advanced Gynecologic and Genitourinary MalignanciesACTIVE_NOT_RECRUITING2025-10-15PHASE22022-07-212025-12-30
NCT06323356A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisACTIVE_NOT_RECRUITING2025-10-15PHASE32024-03-192026-07-22
NCT05337137A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerACTIVE_NOT_RECRUITING2025-10-15PHASE1, PHASE22022-05-052025-11-07
NCT05152147A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersACTIVE_NOT_RECRUITING2025-10-15PHASE32021-12-022026-05-15
NCT03036488Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)ACTIVE_NOT_RECRUITING2025-10-14PHASE32017-03-072025-10-14
NCT03070132802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal NeuralgiaWITHDRAWN2025-10-14PHASE32023-04-192026-08-21
NCT06778057Clinical Performance of Three Daily Disposable Silicone Hydrogel Contact LensesRECRUITING2025-10-13NA2024-12-292025-10-13
NCT04398680A Study of Belantamab Mafodotin in Multiple Myeloma Participants With Normal and Impaired Hepatic FunctionRECRUITING2025-10-13PHASE12021-04-202025-10-13
NCT06890416A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in AdultsACTIVE_NOT_RECRUITING2025-10-13PHASE32025-04-042025-10-13
NCT06435273Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With AsthmaACTIVE_NOT_RECRUITING2025-10-13PHASE22024-08-052025-10-13
NCT06660173A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)ACTIVE_NOT_RECRUITING2025-10-09PHASE22024-11-072026-06-25
NCT04965636Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)ACTIVE_NOT_RECRUITING2025-10-09PHASE32022-07-112025-10-09
NCT04686136A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic MigraineACTIVE_NOT_RECRUITING2025-10-08PHASE32021-02-192025-10-08
NCT03628053Tisagenlecleucel vs Blinatumomab or Inotuzumab for Patients With Relapsed/Refractory B-cell Precursor Acute Lymphoblastic LeukemiaWITHDRAWN2025-10-08PHASE32020-06-052026-01-07
NCT04488133A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)ACTIVE_NOT_RECRUITING2025-10-07PHASE42021-01-042025-10-07
NCT04303169Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02)ACTIVE_NOT_RECRUITING2025-10-06PHASE1, PHASE22020-06-262025-10-06
NCT06236009A First-In-Human Study of TAK-004 in Healthy AdultsCOMPLETED2025-10-06PHASE12024-11-012025-10-06
NCT06864143A Study to Investigate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of AgeRECRUITING2025-10-06PHASE22025-03-072025-10-06
NCT06213818A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult ParticipantRECRUITING2025-10-06PHASE12024-03-142025-10-06
NCT06813781Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD5004RECRUITING2025-10-06PHASE12024-12-192025-10-06
NCT05450692A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based ChemotherapyACTIVE_NOT_RECRUITING2025-10-06PHASE32022-09-152025-10-06